data_2m8b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8b _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 50' ' ' PRO . 19.9 mt . . . . . 0 C--O 1.232 0.151 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . 0.442 ' N ' ' HB2' ' B' ' 51' ' ' CYS . 7.3 m -89.44 113.41 24.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.553 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -75.55 153.26 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.982 -173.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -141.48 126.22 10.54 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.432 ' HA ' HD12 ' B' ' 46' ' ' ILE . 18.9 Cg_endo -59.21 124.34 15.39 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.065 1.843 . . . . 0.0 111.53 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 67.8 m -51.49 112.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.834 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 -0.3 78.23 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -105.88 -6.48 18.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.964 0.887 . . . . 0.0 109.228 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -104.13 168.41 9.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.843 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -159.98 147.06 16.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.28 -151.88 47.47 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.591 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.33 156.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.79 140.5 52.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.236 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.7 26.68 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.237 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.598 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 7.1 p30 -164.05 147.25 9.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.886 0.343 . . . . 0.0 110.539 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -103.18 -31.83 9.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.34 -52.3 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.44 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -59.04 -38.2 78.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -49.69 76.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.95 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.648 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.6 ttp180 -60.08 -53.1 61.72 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 12.7 t30 -53.26 -46.11 69.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.882 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.24 -48.92 79.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.412 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' B' ' 31' ' ' ALA . 92.9 m -55.89 -40.93 73.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.979 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.648 HG12 ' O ' ' B' ' 22' ' ' ARG . 22.1 mm -56.08 -61.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.154 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 10.3 ptm180 -80.58 -42.66 21.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.249 -170.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 44.0 mt -86.52 -43.6 12.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.627 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -102.29 2.49 37.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.06 27.1 16.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.977 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -82.51 151.03 26.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.381 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -85.23 -29.82 24.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.011 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -142.66 160.73 39.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.56 155.35 26.55 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -160.8 170.81 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.094 0.473 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 19.4 t -103.35 75.78 1.37 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.434 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.91 153.23 43.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.789 -172.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -100.63 85.47 2.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 m -82.75 98.03 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 74.5 t80 -44.51 134.29 4.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.433 -174.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 29.3 Cg_endo -100.44 30.17 11.82 Favored 'Cis proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.797 -1.335 . . . . 0.0 114.252 2.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.62 151.82 48.72 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . 0.511 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 32.5 m-70 -84.0 124.39 31.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.985 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -125.36 147.77 49.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.207 0.527 . . . . 0.0 110.355 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 t -79.22 124.17 28.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 38.9 mm -128.06 119.31 50.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.671 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -88.44 145.65 25.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.68 128.3 55.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.85 0.357 . . . . 0.0 111.007 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 138.44 27.05 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.937 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HA ' HD23 ' B' ' 3' ' ' LEU . 62.0 Cg_exo -53.56 116.39 2.95 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 C-N-CA 123.133 2.556 . . . . 0.0 111.947 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.442 ' HB2' ' N ' ' B' ' 4' ' ' CYS . 5.9 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.485 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 m -104.21 126.76 51.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.687 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 0.7 OUTLIER -78.78 140.06 38.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.324 0.583 . . . . 0.0 111.302 -175.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 5' ' ' GLU . 14.2 mptt -133.68 128.47 19.96 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.192 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.48 129.37 26.4 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.82 1.68 . . . . 0.0 110.984 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -55.98 130.64 44.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.304 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.15 9.03 59.41 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.216 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.8 p -116.34 -25.73 7.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.281 0.562 . . . . 0.0 109.932 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -79.6 170.4 16.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.208 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -148.29 131.61 16.55 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.666 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.4 -141.7 32.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.031 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.43 145.52 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.12 144.81 35.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.37 -21.11 3.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.073 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -123.79 125.0 43.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.426 0.155 . . . . 0.0 111.213 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.9 p-10 -77.71 -37.9 48.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 0.0 111.17 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.48 -38.32 21.44 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.57 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.78 78.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 20.7 t -66.14 -47.9 72.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.926 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.649 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.1 ttp180 -54.75 -52.59 62.07 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -55.29 -47.57 75.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.054 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -62.46 -47.15 85.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.224 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . 0.47 ' HB3' ' HB1' ' B' ' 31' ' ' ALA . 96.5 m -54.9 -39.72 69.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.952 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.649 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.7 mm -58.34 -65.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.514 0.674 . . . . 0.0 110.989 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.411 ' HG3' ' HG ' ' B' ' 28' ' ' LEU . 17.3 ptp180 -71.94 -43.26 65.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.083 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.411 ' HG ' ' HG3' ' B' ' 27' ' ' ARG . 69.1 mt -88.16 -42.68 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -172.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.21 -0.1 28.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.51 ' HB2' ' NZ ' ' B' ' 30' ' ' LYS . 7.1 mtmp? 66.29 25.46 10.48 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.322 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' B' ' 25' ' ' CYS . . . -77.32 152.09 34.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.928 0.394 . . . . 0.0 110.85 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 32.6 mmm180 -82.45 -33.42 28.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.494 0.664 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -147.68 160.47 42.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -152.44 151.33 23.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.3 t -150.31 152.57 34.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.037 0.419 . . . . 0.0 110.087 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' B' ' 18' ' ' ASN . 15.6 t -91.45 66.19 5.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.754 0.788 . . . . 0.0 109.09 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.92 157.02 35.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.464 -172.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.23 89.07 7.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.467 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.67 96.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 168.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -40.12 135.61 1.37 Allowed Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 123.823 0.702 . . . . 0.0 111.361 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -100.15 28.47 14.05 Favored 'Cis proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.956 -1.268 . . . . 0.0 114.065 3.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.42 33.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.0 111.956 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -77.27 127.2 32.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.908 173.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -123.08 145.84 48.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 42.6 t -73.75 106.51 5.52 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.913 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.687 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 31.1 mm -110.39 110.16 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.155 0.502 . . . . 0.0 110.653 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 46.0 m -79.06 148.51 32.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.407 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -112.7 123.85 51.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.088 0.47 . . . . 0.0 111.437 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.43 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 95.6 m-85 -121.41 134.83 24.62 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.123 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.5 125.16 15.94 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.85 2.367 . . . . 0.0 112.58 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.77 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.6 114.15 19.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.156 0.503 . . . . 0.0 109.753 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.641 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -68.38 153.07 44.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.262 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -142.47 125.94 9.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.163 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.417 ' HA ' HD11 ' B' ' 46' ' ' ILE . 17.5 Cg_endo -59.53 122.11 10.97 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.347 2.032 . . . . 0.0 111.742 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.4 p -49.49 128.97 18.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.483 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.92 5.67 42.93 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -114.39 -11.63 12.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.57 0.7 . . . . 0.0 110.257 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -92.41 171.1 9.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.876 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.8 m -154.49 139.25 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.602 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.51 -155.33 48.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.381 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.99 156.22 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 120.94 0.4 . . . . 0.0 110.075 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.22 147.35 40.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.446 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.71 22.76 2.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.821 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.548 ' OD1' ' HB2' ' B' ' 20' ' ' ALA . 4.2 p30 -158.17 137.19 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -88.6 -29.61 19.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.048 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.42 -56.68 2.77 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.683 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.548 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . . . -58.55 -36.49 73.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.001 0.429 . . . . 0.0 109.928 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -61.44 -49.05 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.621 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.6 ' O ' HG12 ' B' ' 26' ' ' ILE . 35.9 ttm180 -63.44 -50.4 69.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 109.742 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -56.89 -43.18 81.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -58.7 -51.22 70.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.375 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 99.4 m -53.73 -40.58 66.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.186 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' B' ' 31' ' ' ALA . 19.0 mm -56.68 -58.33 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 121.375 0.607 . . . . 0.0 111.196 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -79.06 -45.84 19.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.925 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.88 -60.26 2.45 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.602 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.91 3.55 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 111.969 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 60.28 31.16 20.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -81.93 148.71 28.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.498 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -85.6 -25.61 26.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . 0.556 ' CE1' ' HD3' ' B' ' 22' ' ' ARG . 36.2 t60 -152.44 177.29 10.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.41 175.8 47.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.585 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 4.8 t -173.6 156.7 3.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 17.2 t -89.77 73.18 7.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.465 0.65 . . . . 0.0 109.258 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.588 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -65.44 151.79 45.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.186 -172.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -92.08 81.47 5.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.353 0.597 . . . . 0.0 110.406 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.55 99.23 5.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 34.9 t80 -44.0 132.86 4.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.452 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 52.9 Cg_endo -101.21 23.36 17.43 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.13 -1.196 . . . . 0.0 114.205 2.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.12 41.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -90.58 125.33 35.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.865 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.52 151.74 50.67 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.094 0.473 . . . . 0.0 110.623 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -76.43 120.49 21.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.641 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 44.5 mm -123.24 116.67 49.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 35.9 m -86.02 136.86 33.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.879 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -101.12 123.33 45.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.863 0.363 . . . . 0.0 110.477 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 94.4 m-85 -116.27 138.46 24.29 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.686 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 13.4 Cg_exo -68.0 116.12 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.463 2.109 . . . . 0.0 111.781 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.364 177.312 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 120.741 0.305 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -112.98 118.06 33.77 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.602 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -67.7 152.36 45.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.848 -173.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -142.55 131.73 11.93 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.13 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.446 ' HA ' HD12 ' B' ' 46' ' ' ILE . 19.0 Cg_endo -58.16 129.58 33.69 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.245 1.964 . . . . 0.0 111.697 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 39.7 t -58.09 132.53 53.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 0.0 110.974 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.3 11.89 47.8 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -117.64 -20.66 8.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.573 0.702 . . . . 0.0 109.727 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -87.73 170.52 11.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.351 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.3 m -140.97 121.1 13.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.68 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.33 -152.03 51.54 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.746 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.72 148.4 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 8.0 p -110.62 146.88 35.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.762 0.315 . . . . 0.0 111.176 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.37 -7.36 34.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.332 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -139.14 108.66 6.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.449 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -73.53 -31.47 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.744 0.307 . . . . 0.0 110.979 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.7 -38.87 22.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.337 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.74 90.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.97 -49.29 78.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.653 ' O ' HG12 ' B' ' 26' ' ' ILE . 43.5 ttp180 -54.31 -55.95 23.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' B' ' 27' ' ' ARG . 40.8 t30 -53.62 -46.99 70.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.551 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -60.65 -48.21 82.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.398 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 92.1 m -54.69 -40.7 69.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.032 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.653 HG12 ' O ' ' B' ' 22' ' ' ARG . 14.7 mm -58.92 -58.76 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.762 0.791 . . . . 0.0 110.303 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 23' ' ' ASN . 70.7 mtp180 -71.29 -51.81 22.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.281 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.01 -26.88 18.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -115.36 4.95 14.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.972 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.13 29.19 18.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.594 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.82 157.57 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.992 0.425 . . . . 0.0 110.475 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -90.0 -26.65 20.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.827 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -153.49 168.56 25.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.11 160.94 34.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -176.1 160.14 2.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' B' ' 43' ' ' HIS . 69.8 m -85.29 91.35 8.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' CG1' ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.25 165.12 21.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -96.32 93.05 6.64 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.332 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -95.87 107.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -45.02 135.49 4.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.864 0.728 . . . . 0.0 111.572 -173.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -100.07 21.61 21.01 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.807 -1.33 . . . . 0.0 113.508 1.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.9 178.81 6.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.353 0.596 . . . . 0.0 112.148 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . 0.438 ' HB3' ' HB3' ' B' ' 36' ' ' CYS . 55.0 m-70 -100.27 119.03 37.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.087 175.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -107.81 145.13 34.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -72.53 115.2 11.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.52 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.602 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 37.8 mm -124.89 128.17 73.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 -174.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.7 m -96.86 151.75 19.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.702 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -111.48 125.44 53.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.4 142.14 31.99 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.201 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.15 118.2 4.57 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.04 2.493 . . . . 0.0 112.392 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.691 -178.347 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' B' ' 50' ' ' PRO . 48.6 mt . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.701 0.286 . . . . 0.0 111.606 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 m -98.17 123.93 42.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.621 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -74.71 150.25 39.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.769 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.422 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 49.6 tttm -133.93 134.28 23.02 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.431 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.03 130.66 31.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.672 1.581 . . . . 0.0 110.619 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -58.72 134.06 56.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.05 16.34 42.78 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -125.98 -26.57 3.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.056 0.455 . . . . 0.0 110.784 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -87.33 170.89 11.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.585 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -148.28 124.03 10.54 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.31 -162.81 54.31 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.78 144.12 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -92.53 167.54 11.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.801 0.334 . . . . 0.0 110.225 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.35 -11.25 10.81 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.891 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.46 -41.43 76.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.26 58.91 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.594 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.73 92.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.74 -46.85 80.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.111 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.634 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.0 ttp180 -60.94 -52.41 65.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.839 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 40.0 t30 -53.48 -46.18 69.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.519 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -59.16 -48.45 81.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 82.3 m -54.64 -43.24 72.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.643 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.634 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.5 mm -55.93 -55.54 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.399 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 23.2 mmt180 -74.74 -63.72 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.565 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.23 -48.79 26.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.836 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.68 -0.2 57.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 59.69 38.59 21.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.06 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -88.69 150.82 22.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -83.54 -25.32 31.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -153.14 167.3 29.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.353 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.3 162.34 35.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 88.0 p -159.6 145.16 15.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.829 0.315 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 6.8 t -82.33 76.18 9.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.438 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -67.43 152.46 45.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.298 -172.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -90.56 77.08 6.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.685 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.27 101.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -43.31 135.13 3.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.393 -173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -101.22 25.94 15.45 Favored 'Cis proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.575 4.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 163.83 31.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . 0.437 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 42.8 m-70 -89.75 117.71 28.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.55 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -119.51 154.83 33.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.14 0.495 . . . . 0.0 110.53 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.36 110.48 10.92 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.249 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.621 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 43.2 mm -118.84 116.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 m -86.89 153.37 21.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.12 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.37 130.52 56.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.956 0.408 . . . . 0.0 111.066 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.1 m-85 -126.42 142.19 42.23 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.167 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' B' ' 3' ' ' LEU . 77.3 Cg_exo -52.16 118.97 5.08 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.803 2.335 . . . . 0.0 111.827 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.44 -177.253 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.038 0.446 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 72.1 m -117.05 116.85 28.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.461 0.648 . . . . 0.0 110.583 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.641 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.5 mp0 -74.72 149.51 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.902 -171.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.69 125.55 11.94 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.538 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' B' ' 46' ' ' ILE . 9.8 Cg_endo -53.71 125.45 18.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.626 2.218 . . . . 0.0 112.477 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -59.15 139.48 56.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.86 13.56 26.93 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -119.93 8.59 11.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.578 0.704 . . . . 0.0 109.898 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -124.45 172.25 9.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.538 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -167.56 158.03 11.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 -164.31 54.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.321 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -83.85 128.74 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 t -81.3 133.28 35.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -29.25 4.12 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.914 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -126.84 114.94 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 111.26 -168.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.3 p-10 -72.94 -32.8 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.95 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.52 -52.05 23.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.579 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.32 -37.67 72.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.9 t -61.5 -47.5 85.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.51 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.663 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.9 ttp85 -62.04 -49.51 75.7 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -59.33 -43.77 92.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.549 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' B' ' 24' ' ' GLN . 1.7 mt-30 -58.19 -45.75 86.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.771 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 87.2 m -60.23 -41.13 92.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.824 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.663 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.9 mm -58.33 -58.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.464 0.65 . . . . 0.0 110.642 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -73.79 -61.37 1.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.666 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 mt -74.46 -40.43 61.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.988 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -107.87 5.27 26.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.989 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt 56.75 32.86 21.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.965 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.99 149.56 29.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.627 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -77.85 -30.94 51.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.071 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -151.8 167.6 27.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.952 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.33 165.05 35.3 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -160.58 155.44 24.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.974 0.387 . . . . 0.0 110.121 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 26.2 t -91.44 72.23 6.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.461 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -62.58 153.6 31.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.598 -172.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -96.54 79.55 3.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.857 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.2 101.25 4.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -46.35 134.73 7.42 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.703 -171.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -102.08 28.04 12.24 Favored 'Cis proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.049 -1.23 . . . . 0.0 113.849 2.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.0 170.81 15.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 112.13 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . 0.624 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 51.4 m-70 -100.01 130.16 46.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -127.65 148.47 50.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.267 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 35.4 t -74.21 117.33 15.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.641 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 36.1 mm -126.63 119.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.455 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 37.5 m -84.21 151.23 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.33 121.78 45.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.086 0.469 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.37 135.32 24.92 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.236 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.88 117.85 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.283 1.989 . . . . 0.0 112.178 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' B' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.318 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.113 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.097 0.475 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 36.4 m -120.38 125.74 48.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.02 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.655 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.9 mp0 -76.89 139.09 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.401 0.62 . . . . 0.0 111.483 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' B' ' 49' ' ' PHE . 2.1 mptm? -132.46 141.46 41.33 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.211 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.33 138.46 60.78 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.06 1.84 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.9 p -59.76 131.79 51.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.371 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.08 14.61 33.79 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.488 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.8 p -131.85 -9.42 3.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . 0.497 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 19.4 t-105 -104.86 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.321 0.582 . . . . 0.0 110.376 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' B' ' 11' ' ' TRP . 26.9 m -89.7 -155.97 0.39 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.768 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.61 -116.14 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.242 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.57 147.74 6.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.487 . . . . 0.0 111.347 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.497 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 6.5 p -130.64 147.93 52.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.227 0.537 . . . . 0.0 110.929 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.64 -45.48 6.41 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.246 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -116.51 126.98 54.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.765 0.317 . . . . 0.0 110.792 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -70.38 -28.08 64.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.65 -34.42 25.15 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.751 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.58 91.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -61.5 -49.24 77.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.792 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.639 ' O ' HG12 ' B' ' 26' ' ' ILE . 50.1 ttp180 -52.5 -55.3 22.96 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.155 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -51.96 -48.58 64.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.903 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -64.0 -44.71 91.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' B' ' 31' ' ' ALA . 74.6 m -55.56 -41.12 72.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.453 174.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.639 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.1 mm -56.97 -59.14 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.47 0.653 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -80.69 -51.02 9.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.345 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -79.36 -42.92 24.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.75 1.46 37.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' B' ' 26' ' ' ILE . 34.7 mmtp 57.81 29.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.885 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -78.26 151.35 33.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.985 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' B' ' 32' ' ' ARG . 4.3 mmp_? -83.11 -24.93 32.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -153.56 167.01 30.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.482 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.34 158.64 31.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.3 m -162.18 151.99 16.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.074 0.437 . . . . 0.0 110.539 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -76.38 81.83 3.12 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.203 0.525 . . . . 0.0 109.986 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 156.98 29.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.98 83.2 7.85 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.835 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 95.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 167.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 82.7 t80 -44.26 135.04 4.26 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.628 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.8 Cg_endo -100.03 29.92 12.44 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.874 -1.302 . . . . 0.0 113.807 1.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.33 167.49 21.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.324 0.583 . . . . 0.0 112.052 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.37 111.07 22.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.827 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -105.75 147.39 28.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.722 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.5 t -73.6 114.98 12.47 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.655 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 30.1 mm -121.13 118.52 56.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.112 0.482 . . . . 0.0 110.887 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.6 m -84.78 148.3 26.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.817 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.01 121.5 45.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.922 0.391 . . . . 0.0 110.916 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.436 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 98.0 m-85 -117.87 138.56 25.47 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.341 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.85 123.15 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.645 2.23 . . . . 0.0 111.982 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.859 178.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.403 HD21 ' HA ' ' B' ' 50' ' ' PRO . 67.0 mt . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.8 m -110.75 122.72 48.52 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -75.55 152.39 37.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.429 0.633 . . . . 0.0 112.035 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 64.2 tttp -137.79 131.32 16.95 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.53 124.91 16.04 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.117 1.878 . . . . 0.0 111.203 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -51.91 133.45 32.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.17 3.78 51.61 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.836 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -115.13 -20.45 10.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -90.63 167.06 12.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.012 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -158.25 151.02 22.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.737 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.83 -149.64 45.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.939 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.18 139.65 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 120.815 0.341 . . . . 0.0 110.603 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.0 t -104.28 148.32 26.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.144 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.62 32.25 1.22 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.8 p30 -165.06 129.79 2.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -89.25 -30.8 18.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.706 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.84 -49.8 5.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.219 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -61.27 -47.93 83.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.269 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.596 ' O ' HG12 ' B' ' 26' ' ' ILE . 55.5 ttp180 -60.75 -51.32 69.85 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.121 0.486 . . . . 0.0 109.746 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -55.08 -48.69 73.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.176 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.51 -45.04 95.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . 0.423 ' HB3' ' HB1' ' B' ' 31' ' ' ALA . 98.8 m -56.17 -42.76 77.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.596 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.8 mm -54.88 -56.72 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.746 0.784 . . . . 0.0 111.004 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.88 -63.6 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.828 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.18 -35.75 69.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.684 -170.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -108.46 3.4 23.15 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.929 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp 58.67 34.32 23.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.041 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -86.77 154.61 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.333 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -90.1 -22.38 21.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.24 166.27 33.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.02 161.73 31.72 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -152.62 144.77 23.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.807 0.304 . . . . 0.0 110.666 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 35.8 t -90.43 79.94 6.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.448 ' ND2' HG13 ' B' ' 46' ' ' ILE . 23.1 p-10 -71.07 167.78 18.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.316 -171.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -110.62 77.37 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.075 0.464 . . . . 0.0 110.273 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.52 102.1 6.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -43.22 137.2 2.85 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.173 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.86 24.54 18.7 Favored 'Cis proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.155 -1.185 . . . . 0.0 114.694 3.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.92 163.4 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 112.241 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 54.9 m-70 -86.24 128.12 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.303 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -118.01 168.88 10.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.166 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.02 116.08 28.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.662 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 45.8 mm -115.98 117.15 54.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.534 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.01 145.48 27.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.02 122.53 47.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.923 0.392 . . . . 0.0 110.766 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.0 m-85 -116.5 139.19 25.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.874 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' B' ' 3' ' ' LEU . 53.4 Cg_exo -53.14 115.68 2.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.811 2.341 . . . . 0.0 111.656 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.263 -174.308 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 52.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 99.0 m -109.17 129.0 55.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.577 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.0 OUTLIER -84.19 147.91 27.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.491 0.662 . . . . 0.0 112.019 -170.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -136.29 126.4 16.25 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.679 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.456 ' HA ' HD13 ' B' ' 46' ' ' ILE . 26.9 Cg_exo -60.45 133.68 50.44 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.069 1.846 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 79.2 p -53.08 127.77 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.565 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.89 4.07 56.01 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.4 p -120.17 -0.88 10.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.48 0.657 . . . . 0.0 110.334 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 6.3 t-105 -126.21 169.83 12.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -160.66 133.31 6.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.24 -165.67 34.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.942 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.99 120.32 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.057 0.456 . . . . 0.0 110.003 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.443 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 3.3 p -88.85 135.65 33.42 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.95 38.57 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.815 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -122.01 120.89 35.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.805 0.336 . . . . 0.0 110.553 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -66.67 -31.18 71.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.693 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.74 -36.45 37.18 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.49 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.51 91.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -59.93 -47.25 86.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.72 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.67 ' O ' HG12 ' B' ' 26' ' ' ILE . 38.9 ttt180 -58.95 -52.13 67.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -58.42 -36.51 73.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.321 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.408 ' NE2' ' HE3' ' B' ' 11' ' ' TRP . 0.0 OUTLIER -69.29 -43.8 73.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 72.7 m -58.73 -40.19 83.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.596 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.67 HG12 ' O ' ' B' ' 22' ' ' ARG . 26.8 mm -54.61 -60.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.71 0.767 . . . . 0.0 110.756 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -69.02 -61.9 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.757 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -79.95 -43.24 22.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.223 -168.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.57 1.2 40.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.939 -172.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 58.9 36.0 24.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.968 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -88.35 151.12 22.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -83.73 -33.43 25.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . 0.525 ' CE1' ' HD2' ' B' ' 22' ' ' ARG . 73.5 t60 -139.66 166.48 24.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -161.95 156.4 27.94 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -170.14 154.03 4.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.199 0.499 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -84.89 81.44 8.89 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.521 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 160.64 11.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.675 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -98.56 85.24 3.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 111.497 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.78 104.61 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -46.65 135.55 7.78 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.365 -174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -99.59 21.37 22.27 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.962 -1.266 . . . . 0.0 113.417 0.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.5 -175.51 3.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.275 0.559 . . . . 0.0 111.834 -172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -114.98 133.41 56.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.092 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -123.53 148.98 45.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.287 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.62 120.54 20.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.209 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 32.6 mm -127.11 119.72 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 25.4 m -86.68 142.57 28.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.487 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 85.0 m-85 -110.58 122.57 48.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.042 0.448 . . . . 0.0 111.048 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 90.7 m-85 -113.91 135.31 22.04 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.484 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 38.4 Cg_exo -59.4 125.04 16.84 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.042 2.495 . . . . 0.0 113.072 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.298 -0.858 . . . . 0.0 109.953 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -93.03 120.35 33.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.954 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.649 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 7.9 mp0 -81.98 136.48 35.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.946 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -131.01 123.85 20.19 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.55 125.99 20.33 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.544 2.163 . . . . 0.0 111.909 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -55.82 143.66 30.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.285 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.91 10.87 20.79 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.189 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -118.44 -19.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' B' ' 15' ' ' CYS . 7.3 t-105 -98.66 171.77 7.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.987 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.0 p -157.17 129.02 7.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 -148.27 39.49 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.674 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 142.31 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 120.919 0.39 . . . . 0.0 110.347 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.484 ' HA ' ' NE1' ' B' ' 11' ' ' TRP . 15.6 p -96.03 170.68 9.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.03 -62.79 2.28 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.592 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -154.22 167.19 30.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -54.37 -50.47 67.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.41 0.444 . . . . 0.0 111.852 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.32 -36.22 78.09 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.243 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.26 78.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.155 0.503 . . . . 0.0 109.795 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' B' ' 36' ' ' CYS . 25.3 t -69.18 -46.65 66.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.825 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.644 ' O ' HG12 ' B' ' 26' ' ' ILE . 42.9 ttp180 -56.64 -54.4 46.47 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.953 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -61.98 -48.71 79.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.159 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -54.9 -41.09 70.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.027 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.644 HG12 ' O ' ' B' ' 22' ' ' ARG . 18.5 mm -56.09 -60.15 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.772 0.796 . . . . 0.0 110.475 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.95 -56.17 5.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.88 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.64 -32.56 31.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.795 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -112.47 6.48 18.59 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.609 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 55.35 35.23 24.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.431 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -84.21 153.47 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.852 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -88.03 -28.2 21.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 0.0 110.778 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -148.81 171.12 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.49 156.75 26.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.6 m -161.56 134.85 6.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' B' ' 21' ' ' CYS . 97.4 m -67.04 139.0 57.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.958 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' B' ' 43' ' ' HIS . 36.0 p-10 -117.6 169.86 9.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.202 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.79 64.32 0.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.244 0.545 . . . . 0.0 110.248 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.76 92.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 167.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 81.5 t80 -46.47 138.15 6.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.851 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.519 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.3 Cg_endo -100.26 29.62 12.59 Favored 'Cis proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.143 -1.191 . . . . 0.0 114.758 4.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.73 151.02 46.77 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.418 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 9.2 m-70 -89.96 91.99 8.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.875 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.33 174.02 11.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.005 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 45.4 t -100.1 116.47 32.2 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.079 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.649 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 35.4 mm -116.08 116.51 52.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.056 0.455 . . . . 0.0 110.427 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 m -83.38 149.83 26.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.054 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.29 125.07 53.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.058 0.456 . . . . 0.0 111.032 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.56 139.69 28.24 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.545 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.19 124.82 17.19 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.807 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.127 178.126 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.413 0.149 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -74.86 -168.41 0.73 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.389 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 50' ' ' PRO . 19.9 mt -52.37 134.64 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.293 172.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . 0.442 ' N ' ' HB2' ' B' ' 51' ' ' CYS . 7.3 m -89.44 113.41 24.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.553 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -75.55 153.26 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.982 -173.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -141.48 126.22 10.54 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.432 ' HA ' HD12 ' B' ' 46' ' ' ILE . 18.9 Cg_endo -59.21 124.34 15.39 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.065 1.843 . . . . 0.0 111.53 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 67.8 m -51.49 112.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.834 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 -0.3 78.23 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -105.88 -6.48 18.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.964 0.887 . . . . 0.0 109.228 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -104.13 168.41 9.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.843 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -159.98 147.06 16.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.28 -151.88 47.47 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.591 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.33 156.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.79 140.5 52.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.236 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.7 26.68 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.237 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.598 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 7.1 p30 -164.05 147.25 9.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.886 0.343 . . . . 0.0 110.539 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -103.18 -31.83 9.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.34 -52.3 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.44 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -59.04 -38.2 78.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -49.69 76.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.95 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.648 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.6 ttp180 -60.08 -53.1 61.72 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 12.7 t30 -53.26 -46.11 69.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.882 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.24 -48.92 79.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.412 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' B' ' 31' ' ' ALA . 92.9 m -55.89 -40.93 73.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.979 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.648 HG12 ' O ' ' B' ' 22' ' ' ARG . 22.1 mm -56.08 -61.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.154 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 10.3 ptm180 -80.58 -42.66 21.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.249 -170.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 44.0 mt -86.52 -43.6 12.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.627 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -102.29 2.49 37.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.06 27.1 16.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.977 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -82.51 151.03 26.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.381 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -85.23 -29.82 24.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.011 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -142.66 160.73 39.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.56 155.35 26.55 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -160.8 170.81 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.094 0.473 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 19.4 t -103.35 75.78 1.37 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.434 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.91 153.23 43.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.789 -172.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -100.63 85.47 2.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 m -82.75 98.03 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.456 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 74.5 t80 -44.51 134.29 4.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.433 -174.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 29.3 Cg_endo -100.44 30.17 11.82 Favored 'Cis proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.797 -1.335 . . . . 0.0 114.252 2.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.62 151.82 48.72 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . 0.511 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 32.5 m-70 -84.0 124.39 31.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.985 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -125.36 147.77 49.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.207 0.527 . . . . 0.0 110.355 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 6.1 t -79.22 124.17 28.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 38.9 mm -128.06 119.31 50.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.671 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -88.44 145.65 25.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.68 128.3 55.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.85 0.357 . . . . 0.0 111.007 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 138.44 27.05 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.937 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HA ' HD23 ' B' ' 3' ' ' LEU . 62.0 Cg_exo -53.56 116.39 2.95 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 C-N-CA 123.133 2.556 . . . . 0.0 111.947 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.442 ' HB2' ' N ' ' B' ' 4' ' ' CYS . 5.9 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.485 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.03 0.443 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -89.03 -163.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.501 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 26.9 mt -68.14 154.64 41.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.16 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 m -104.21 126.76 51.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.687 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 0.7 OUTLIER -78.78 140.06 38.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.324 0.583 . . . . 0.0 111.302 -175.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 5' ' ' GLU . 14.2 mptt -133.68 128.47 19.96 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.192 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.48 129.37 26.4 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.82 1.68 . . . . 0.0 110.984 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -55.98 130.64 44.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.304 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.15 9.03 59.41 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.216 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.8 p -116.34 -25.73 7.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.281 0.562 . . . . 0.0 109.932 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -79.6 170.4 16.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.208 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -148.29 131.61 16.55 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.666 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.4 -141.7 32.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.031 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.43 145.52 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.12 144.81 35.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.37 -21.11 3.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.073 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -123.79 125.0 43.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.426 0.155 . . . . 0.0 111.213 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.9 p-10 -77.71 -37.9 48.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 0.0 111.17 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.48 -38.32 21.44 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.57 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -34.78 78.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 20.7 t -66.14 -47.9 72.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.926 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.649 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.1 ttp180 -54.75 -52.59 62.07 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -55.29 -47.57 75.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.054 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -62.46 -47.15 85.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.224 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.47 ' HB3' ' HB1' ' B' ' 31' ' ' ALA . 96.5 m -54.9 -39.72 69.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.952 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.649 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.7 mm -58.34 -65.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.514 0.674 . . . . 0.0 110.989 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.411 ' HG3' ' HG ' ' B' ' 28' ' ' LEU . 17.3 ptp180 -71.94 -43.26 65.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.083 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.411 ' HG ' ' HG3' ' B' ' 27' ' ' ARG . 69.1 mt -88.16 -42.68 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -172.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.21 -0.1 28.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.51 ' HB2' ' NZ ' ' B' ' 30' ' ' LYS . 7.1 mtmp? 66.29 25.46 10.48 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.322 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' B' ' 25' ' ' CYS . . . -77.32 152.09 34.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.928 0.394 . . . . 0.0 110.85 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 32.6 mmm180 -82.45 -33.42 28.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.494 0.664 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -147.68 160.47 42.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -152.44 151.33 23.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.3 t -150.31 152.57 34.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.037 0.419 . . . . 0.0 110.087 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' B' ' 18' ' ' ASN . 15.6 t -91.45 66.19 5.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.754 0.788 . . . . 0.0 109.09 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.92 157.02 35.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.464 -172.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.23 89.07 7.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.467 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.67 96.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 168.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -40.12 135.61 1.37 Allowed Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 123.823 0.702 . . . . 0.0 111.361 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -100.15 28.47 14.05 Favored 'Cis proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.956 -1.268 . . . . 0.0 114.065 3.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.42 33.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.0 111.956 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -77.27 127.2 32.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.908 173.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -123.08 145.84 48.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 42.6 t -73.75 106.51 5.52 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.913 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.687 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 31.1 mm -110.39 110.16 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.155 0.502 . . . . 0.0 110.653 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 46.0 m -79.06 148.51 32.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.407 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -112.7 123.85 51.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.088 0.47 . . . . 0.0 111.437 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.43 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 95.6 m-85 -121.41 134.83 24.62 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.123 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.5 125.16 15.94 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.85 2.367 . . . . 0.0 112.58 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.77 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -76.52 96.11 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.958 0.885 . . . . 0.0 110.097 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.48 154.21 50.13 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.44 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.6 114.15 19.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.156 0.503 . . . . 0.0 109.753 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.641 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -68.38 153.07 44.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.262 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -142.47 125.94 9.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.163 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.417 ' HA ' HD11 ' B' ' 46' ' ' ILE . 17.5 Cg_endo -59.53 122.11 10.97 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.347 2.032 . . . . 0.0 111.742 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.4 p -49.49 128.97 18.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.483 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.92 5.67 42.93 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -114.39 -11.63 12.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.57 0.7 . . . . 0.0 110.257 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -92.41 171.1 9.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.876 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.8 m -154.49 139.25 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.602 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.51 -155.33 48.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.381 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.99 156.22 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 120.94 0.4 . . . . 0.0 110.075 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.22 147.35 40.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.446 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.71 22.76 2.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.821 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.548 ' OD1' ' HB2' ' B' ' 20' ' ' ALA . 4.2 p30 -158.17 137.19 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -88.6 -29.61 19.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.048 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.42 -56.68 2.77 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.683 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.548 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . . . -58.55 -36.49 73.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.001 0.429 . . . . 0.0 109.928 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -61.44 -49.05 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.621 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.6 ' O ' HG12 ' B' ' 26' ' ' ILE . 35.9 ttm180 -63.44 -50.4 69.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 109.742 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -56.89 -43.18 81.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -58.7 -51.22 70.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.375 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 99.4 m -53.73 -40.58 66.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.186 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' B' ' 31' ' ' ALA . 19.0 mm -56.68 -58.33 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 121.375 0.607 . . . . 0.0 111.196 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -79.06 -45.84 19.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.925 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.88 -60.26 2.45 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.602 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.91 3.55 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 111.969 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 60.28 31.16 20.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -81.93 148.71 28.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.498 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -85.6 -25.61 26.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . 0.556 ' CE1' ' HD3' ' B' ' 22' ' ' ARG . 36.2 t60 -152.44 177.29 10.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.41 175.8 47.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.585 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 4.8 t -173.6 156.7 3.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 17.2 t -89.77 73.18 7.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.465 0.65 . . . . 0.0 109.258 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.588 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -65.44 151.79 45.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.186 -172.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -92.08 81.47 5.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.353 0.597 . . . . 0.0 110.406 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.55 99.23 5.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 34.9 t80 -44.0 132.86 4.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.452 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 52.9 Cg_endo -101.21 23.36 17.43 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.13 -1.196 . . . . 0.0 114.205 2.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.12 41.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -90.58 125.33 35.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.865 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.52 151.74 50.67 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.094 0.473 . . . . 0.0 110.623 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -76.43 120.49 21.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.641 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 44.5 mm -123.24 116.67 49.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 35.9 m -86.02 136.86 33.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.879 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -101.12 123.33 45.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.863 0.363 . . . . 0.0 110.477 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 94.4 m-85 -116.27 138.46 24.29 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.686 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 13.4 Cg_exo -68.0 116.12 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.463 2.109 . . . . 0.0 111.781 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.364 177.312 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.15 41.18 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 111.24 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 64.8 mt -127.09 136.16 51.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.553 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -112.98 118.06 33.77 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.602 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -67.7 152.36 45.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.848 -173.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -142.55 131.73 11.93 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.13 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.446 ' HA ' HD12 ' B' ' 46' ' ' ILE . 19.0 Cg_endo -58.16 129.58 33.69 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.245 1.964 . . . . 0.0 111.697 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 39.7 t -58.09 132.53 53.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 0.0 110.974 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.3 11.89 47.8 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -117.64 -20.66 8.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.573 0.702 . . . . 0.0 109.727 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -87.73 170.52 11.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.351 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.3 m -140.97 121.1 13.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.68 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.33 -152.03 51.54 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.746 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.72 148.4 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 8.0 p -110.62 146.88 35.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.762 0.315 . . . . 0.0 111.176 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.37 -7.36 34.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.332 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -139.14 108.66 6.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.449 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -73.53 -31.47 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.744 0.307 . . . . 0.0 110.979 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.7 -38.87 22.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.337 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.09 -38.74 90.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.97 -49.29 78.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.653 ' O ' HG12 ' B' ' 26' ' ' ILE . 43.5 ttp180 -54.31 -55.95 23.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' B' ' 27' ' ' ARG . 40.8 t30 -53.62 -46.99 70.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.551 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -60.65 -48.21 82.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.398 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 92.1 m -54.69 -40.7 69.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.032 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.653 HG12 ' O ' ' B' ' 22' ' ' ARG . 14.7 mm -58.92 -58.76 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.762 0.791 . . . . 0.0 110.303 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 23' ' ' ASN . 70.7 mtp180 -71.29 -51.81 22.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.281 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.01 -26.88 18.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -115.36 4.95 14.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.972 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.13 29.19 18.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.594 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.82 157.57 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.992 0.425 . . . . 0.0 110.475 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -90.0 -26.65 20.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.827 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -153.49 168.56 25.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.11 160.94 34.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -176.1 160.14 2.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' B' ' 43' ' ' HIS . 69.8 m -85.29 91.35 8.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' CG1' ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.25 165.12 21.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -96.32 93.05 6.64 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.332 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -95.87 107.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -45.02 135.49 4.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.864 0.728 . . . . 0.0 111.572 -173.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -100.07 21.61 21.01 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.807 -1.33 . . . . 0.0 113.508 1.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.9 178.81 6.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.353 0.596 . . . . 0.0 112.148 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . 0.438 ' HB3' ' HB3' ' B' ' 36' ' ' CYS . 55.0 m-70 -100.27 119.03 37.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.087 175.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -107.81 145.13 34.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -72.53 115.2 11.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.52 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.602 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 37.8 mm -124.89 128.17 73.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 -174.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.7 m -96.86 151.75 19.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.702 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -111.48 125.44 53.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.4 142.14 31.99 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.201 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.15 118.2 4.57 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.04 2.493 . . . . 0.0 112.392 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.691 -178.347 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.94 0.4 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -90.53 -166.56 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.16 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.431 HD21 ' HA ' ' B' ' 50' ' ' PRO . 48.6 mt -44.42 132.47 6.02 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.758 0.662 . . . . 0.0 111.606 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 m -98.17 123.93 42.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.621 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -74.71 150.25 39.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.769 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.422 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 49.6 tttm -133.93 134.28 23.02 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.431 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.03 130.66 31.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.672 1.581 . . . . 0.0 110.619 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -58.72 134.06 56.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.05 16.34 42.78 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -125.98 -26.57 3.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.056 0.455 . . . . 0.0 110.784 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -87.33 170.89 11.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.585 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -148.28 124.03 10.54 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.31 -162.81 54.31 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.78 144.12 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -92.53 167.54 11.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.801 0.334 . . . . 0.0 110.225 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.35 -11.25 10.81 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.891 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.46 -41.43 76.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.26 58.91 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.594 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.73 92.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.74 -46.85 80.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.111 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.634 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.0 ttp180 -60.94 -52.41 65.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.839 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 40.0 t30 -53.48 -46.18 69.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.519 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -59.16 -48.45 81.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 82.3 m -54.64 -43.24 72.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.643 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.634 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.5 mm -55.93 -55.54 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.399 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 23.2 mmt180 -74.74 -63.72 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.565 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.23 -48.79 26.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.836 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.68 -0.2 57.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 59.69 38.59 21.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.06 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -88.69 150.82 22.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -83.54 -25.32 31.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -153.14 167.3 29.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.353 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.3 162.34 35.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 88.0 p -159.6 145.16 15.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.829 0.315 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 6.8 t -82.33 76.18 9.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.438 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -67.43 152.46 45.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.298 -172.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -90.56 77.08 6.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.685 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.27 101.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -43.31 135.13 3.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.393 -173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -101.22 25.94 15.45 Favored 'Cis proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.575 4.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 163.83 31.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . 0.437 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 42.8 m-70 -89.75 117.71 28.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.55 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -119.51 154.83 33.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.14 0.495 . . . . 0.0 110.53 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.36 110.48 10.92 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.249 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.621 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 43.2 mm -118.84 116.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 m -86.89 153.37 21.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.12 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.37 130.52 56.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.956 0.408 . . . . 0.0 111.066 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.1 m-85 -126.42 142.19 42.23 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.167 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' B' ' 3' ' ' LEU . 77.3 Cg_exo -52.16 118.97 5.08 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.803 2.335 . . . . 0.0 111.827 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.44 -177.253 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.478 0.18 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' B' ' 3' ' ' LEU . 30.1 ptt180 -82.67 -170.03 2.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.462 ' O ' ' HG3' ' B' ' 2' ' ' ARG . 33.4 mt -54.7 160.64 1.78 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.446 . . . . 0.0 110.803 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 72.1 m -117.05 116.85 28.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.461 0.648 . . . . 0.0 110.583 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.641 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.5 mp0 -74.72 149.51 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.902 -171.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.69 125.55 11.94 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.538 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' B' ' 46' ' ' ILE . 9.8 Cg_endo -53.71 125.45 18.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.626 2.218 . . . . 0.0 112.477 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -59.15 139.48 56.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.86 13.56 26.93 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -119.93 8.59 11.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.578 0.704 . . . . 0.0 109.898 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -124.45 172.25 9.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.538 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -167.56 158.03 11.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 -164.31 54.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.321 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -83.85 128.74 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 t -81.3 133.28 35.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -29.25 4.12 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.914 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -126.84 114.94 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 111.26 -168.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.3 p-10 -72.94 -32.8 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.95 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.52 -52.05 23.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.579 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.32 -37.67 72.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.9 t -61.5 -47.5 85.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.51 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.663 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.9 ttp85 -62.04 -49.51 75.7 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -59.33 -43.77 92.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.549 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' B' ' 24' ' ' GLN . 1.7 mt-30 -58.19 -45.75 86.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.771 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 87.2 m -60.23 -41.13 92.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.824 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.663 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.9 mm -58.33 -58.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.464 0.65 . . . . 0.0 110.642 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -73.79 -61.37 1.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.666 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 mt -74.46 -40.43 61.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.988 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -107.87 5.27 26.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.989 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt 56.75 32.86 21.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.965 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.99 149.56 29.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.627 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -77.85 -30.94 51.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.071 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -151.8 167.6 27.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.952 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.33 165.05 35.3 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -160.58 155.44 24.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.974 0.387 . . . . 0.0 110.121 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 26.2 t -91.44 72.23 6.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.461 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -62.58 153.6 31.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.598 -172.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -96.54 79.55 3.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.857 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.2 101.25 4.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -46.35 134.73 7.42 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.703 -171.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -102.08 28.04 12.24 Favored 'Cis proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.049 -1.23 . . . . 0.0 113.849 2.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.0 170.81 15.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 112.13 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . 0.624 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 51.4 m-70 -100.01 130.16 46.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -127.65 148.47 50.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.267 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 35.4 t -74.21 117.33 15.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.641 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 36.1 mm -126.63 119.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.455 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 37.5 m -84.21 151.23 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.33 121.78 45.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.086 0.469 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.37 135.32 24.92 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.236 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.88 117.85 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.283 1.989 . . . . 0.0 112.178 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' B' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.318 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.113 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.937 0.399 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -99.8 -163.1 1.0 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.394 . . . . 0.0 110.374 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.0 164.63 25.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.897 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 36.4 m -120.38 125.74 48.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.02 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.655 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.9 mp0 -76.89 139.09 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.401 0.62 . . . . 0.0 111.483 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' B' ' 49' ' ' PHE . 2.1 mptm? -132.46 141.46 41.33 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.211 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.33 138.46 60.78 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.06 1.84 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.9 p -59.76 131.79 51.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.371 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.08 14.61 33.79 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.488 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.8 p -131.85 -9.42 3.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.497 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 19.4 t-105 -104.86 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.321 0.582 . . . . 0.0 110.376 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' B' ' 11' ' ' TRP . 26.9 m -89.7 -155.97 0.39 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.768 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.61 -116.14 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.242 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.57 147.74 6.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.487 . . . . 0.0 111.347 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.497 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 6.5 p -130.64 147.93 52.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.227 0.537 . . . . 0.0 110.929 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.64 -45.48 6.41 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.246 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -116.51 126.98 54.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.765 0.317 . . . . 0.0 110.792 -173.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -70.38 -28.08 64.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.65 -34.42 25.15 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.751 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.58 91.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -61.5 -49.24 77.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.792 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.639 ' O ' HG12 ' B' ' 26' ' ' ILE . 50.1 ttp180 -52.5 -55.3 22.96 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.155 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -51.96 -48.58 64.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.903 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -64.0 -44.71 91.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' B' ' 31' ' ' ALA . 74.6 m -55.56 -41.12 72.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.453 174.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.639 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.1 mm -56.97 -59.14 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.47 0.653 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -80.69 -51.02 9.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.345 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -79.36 -42.92 24.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.75 1.46 37.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' B' ' 26' ' ' ILE . 34.7 mmtp 57.81 29.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.885 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -78.26 151.35 33.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.985 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' B' ' 32' ' ' ARG . 4.3 mmp_? -83.11 -24.93 32.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -153.56 167.01 30.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.482 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.34 158.64 31.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.3 m -162.18 151.99 16.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.074 0.437 . . . . 0.0 110.539 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -76.38 81.83 3.12 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.203 0.525 . . . . 0.0 109.986 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 156.98 29.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.98 83.2 7.85 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.835 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 95.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 167.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 82.7 t80 -44.26 135.04 4.26 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.628 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.8 Cg_endo -100.03 29.92 12.44 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.874 -1.302 . . . . 0.0 113.807 1.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.33 167.49 21.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.324 0.583 . . . . 0.0 112.052 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.37 111.07 22.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.827 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -105.75 147.39 28.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.722 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.5 t -73.6 114.98 12.47 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.655 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 30.1 mm -121.13 118.52 56.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.112 0.482 . . . . 0.0 110.887 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.6 m -84.78 148.3 26.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.817 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.01 121.5 45.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.922 0.391 . . . . 0.0 110.916 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.436 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 98.0 m-85 -117.87 138.56 25.47 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.341 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.85 123.15 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.645 2.23 . . . . 0.0 111.982 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.859 178.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -80.69 46.69 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.53 0.681 . . . . 0.0 110.5 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.403 HD21 ' HA ' ' B' ' 50' ' ' PRO . 67.0 mt -125.84 136.3 52.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 -171.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.8 m -110.75 122.72 48.52 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -75.55 152.39 37.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.429 0.633 . . . . 0.0 112.035 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 64.2 tttp -137.79 131.32 16.95 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.53 124.91 16.04 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.117 1.878 . . . . 0.0 111.203 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -51.91 133.45 32.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.17 3.78 51.61 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.836 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -115.13 -20.45 10.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -90.63 167.06 12.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.012 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -158.25 151.02 22.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.737 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.83 -149.64 45.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.939 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.18 139.65 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 120.815 0.341 . . . . 0.0 110.603 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.0 t -104.28 148.32 26.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.144 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.62 32.25 1.22 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.8 p30 -165.06 129.79 2.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -89.25 -30.8 18.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.706 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.84 -49.8 5.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.219 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -61.27 -47.93 83.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.269 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.596 ' O ' HG12 ' B' ' 26' ' ' ILE . 55.5 ttp180 -60.75 -51.32 69.85 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.121 0.486 . . . . 0.0 109.746 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -55.08 -48.69 73.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.176 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.51 -45.04 95.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.423 ' HB3' ' HB1' ' B' ' 31' ' ' ALA . 98.8 m -56.17 -42.76 77.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.596 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.8 mm -54.88 -56.72 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.746 0.784 . . . . 0.0 111.004 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.88 -63.6 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.828 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.18 -35.75 69.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.684 -170.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -108.46 3.4 23.15 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.929 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp 58.67 34.32 23.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.041 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -86.77 154.61 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.333 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -90.1 -22.38 21.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.24 166.27 33.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.02 161.73 31.72 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -152.62 144.77 23.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.807 0.304 . . . . 0.0 110.666 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 35.8 t -90.43 79.94 6.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.448 ' ND2' HG13 ' B' ' 46' ' ' ILE . 23.1 p-10 -71.07 167.78 18.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.316 -171.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -110.62 77.37 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.075 0.464 . . . . 0.0 110.273 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.52 102.1 6.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -43.22 137.2 2.85 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.173 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.86 24.54 18.7 Favored 'Cis proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.155 -1.185 . . . . 0.0 114.694 3.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.92 163.4 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 112.241 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 54.9 m-70 -86.24 128.12 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.303 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -118.01 168.88 10.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.166 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.02 116.08 28.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.662 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 45.8 mm -115.98 117.15 54.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.534 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.01 145.48 27.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.02 122.53 47.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.923 0.392 . . . . 0.0 110.766 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.0 m-85 -116.5 139.19 25.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.874 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' B' ' 3' ' ' LEU . 53.4 Cg_exo -53.14 115.68 2.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.811 2.341 . . . . 0.0 111.656 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.263 -174.308 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.094 0.474 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -90.2 -178.1 5.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 0.0 111.76 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.75 145.67 34.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.915 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 99.0 m -109.17 129.0 55.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.577 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.0 OUTLIER -84.19 147.91 27.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.491 0.662 . . . . 0.0 112.019 -170.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -136.29 126.4 16.25 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.679 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.456 ' HA ' HD13 ' B' ' 46' ' ' ILE . 26.9 Cg_exo -60.45 133.68 50.44 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.069 1.846 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 79.2 p -53.08 127.77 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.565 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.89 4.07 56.01 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.4 p -120.17 -0.88 10.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.48 0.657 . . . . 0.0 110.334 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 6.3 t-105 -126.21 169.83 12.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -160.66 133.31 6.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.24 -165.67 34.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.942 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.99 120.32 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.057 0.456 . . . . 0.0 110.003 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.443 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 3.3 p -88.85 135.65 33.42 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.95 38.57 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.815 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -122.01 120.89 35.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.805 0.336 . . . . 0.0 110.553 -173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -66.67 -31.18 71.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.693 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.74 -36.45 37.18 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.49 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.51 91.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -59.93 -47.25 86.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.72 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.67 ' O ' HG12 ' B' ' 26' ' ' ILE . 38.9 ttt180 -58.95 -52.13 67.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -58.42 -36.51 73.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.321 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.408 ' NE2' ' HE3' ' B' ' 11' ' ' TRP . 0.0 OUTLIER -69.29 -43.8 73.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 72.7 m -58.73 -40.19 83.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.596 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.67 HG12 ' O ' ' B' ' 22' ' ' ARG . 26.8 mm -54.61 -60.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.71 0.767 . . . . 0.0 110.756 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -69.02 -61.9 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.757 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -79.95 -43.24 22.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.223 -168.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.57 1.2 40.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.939 -172.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 58.9 36.0 24.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.968 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -88.35 151.12 22.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -83.73 -33.43 25.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . 0.525 ' CE1' ' HD2' ' B' ' 22' ' ' ARG . 73.5 t60 -139.66 166.48 24.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -161.95 156.4 27.94 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -170.14 154.03 4.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.199 0.499 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -84.89 81.44 8.89 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.521 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 160.64 11.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.675 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -98.56 85.24 3.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 111.497 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.78 104.61 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -46.65 135.55 7.78 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.365 -174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -99.59 21.37 22.27 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.962 -1.266 . . . . 0.0 113.417 0.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.5 -175.51 3.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.275 0.559 . . . . 0.0 111.834 -172.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -114.98 133.41 56.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.092 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -123.53 148.98 45.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.287 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.62 120.54 20.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.209 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 32.6 mm -127.11 119.72 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 25.4 m -86.68 142.57 28.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.487 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 85.0 m-85 -110.58 122.57 48.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.042 0.448 . . . . 0.0 111.048 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 90.7 m-85 -113.91 135.31 22.04 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.484 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 38.4 Cg_exo -59.4 125.04 16.84 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.042 2.495 . . . . 0.0 113.072 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.298 -0.858 . . . . 0.0 109.953 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.838 0.351 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -121.46 -168.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.183 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt -54.05 152.18 6.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.8 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -93.03 120.35 33.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.954 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.649 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 7.9 mp0 -81.98 136.48 35.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.946 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -131.01 123.85 20.19 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.55 125.99 20.33 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.544 2.163 . . . . 0.0 111.909 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -55.82 143.66 30.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.285 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.91 10.87 20.79 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.189 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -118.44 -19.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' B' ' 15' ' ' CYS . 7.3 t-105 -98.66 171.77 7.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.987 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.0 p -157.17 129.02 7.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 -148.27 39.49 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.674 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 142.31 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 120.919 0.39 . . . . 0.0 110.347 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.484 ' HA ' ' NE1' ' B' ' 11' ' ' TRP . 15.6 p -96.03 170.68 9.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.03 -62.79 2.28 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.592 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -154.22 167.19 30.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -54.37 -50.47 67.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.41 0.444 . . . . 0.0 111.852 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.32 -36.22 78.09 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.243 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.26 78.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.155 0.503 . . . . 0.0 109.795 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' B' ' 36' ' ' CYS . 25.3 t -69.18 -46.65 66.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.825 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.644 ' O ' HG12 ' B' ' 26' ' ' ILE . 42.9 ttp180 -56.64 -54.4 46.47 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.953 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -61.98 -48.71 79.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.159 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -54.9 -41.09 70.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.027 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.644 HG12 ' O ' ' B' ' 22' ' ' ARG . 18.5 mm -56.09 -60.15 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.772 0.796 . . . . 0.0 110.475 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.95 -56.17 5.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.88 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.64 -32.56 31.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.795 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -112.47 6.48 18.59 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.609 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 55.35 35.23 24.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.431 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -84.21 153.47 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.852 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -88.03 -28.2 21.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 0.0 110.778 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -148.81 171.12 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.49 156.75 26.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.6 m -161.56 134.85 6.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' B' ' 21' ' ' CYS . 97.4 m -67.04 139.0 57.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.958 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' B' ' 43' ' ' HIS . 36.0 p-10 -117.6 169.86 9.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.202 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.79 64.32 0.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.244 0.545 . . . . 0.0 110.248 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.76 92.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 167.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 81.5 t80 -46.47 138.15 6.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.851 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.519 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.3 Cg_endo -100.26 29.62 12.59 Favored 'Cis proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.143 -1.191 . . . . 0.0 114.758 4.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.73 151.02 46.77 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.418 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 9.2 m-70 -89.96 91.99 8.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.875 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.33 174.02 11.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.005 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 45.4 t -100.1 116.47 32.2 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.079 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.649 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 35.4 mm -116.08 116.51 52.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.056 0.455 . . . . 0.0 110.427 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 m -83.38 149.83 26.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.054 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.29 125.07 53.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.058 0.456 . . . . 0.0 111.032 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.56 139.69 28.24 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.545 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.19 124.82 17.19 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.807 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.127 178.126 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' B' ' 50' ' ' PRO . 19.9 mt . . . . . 0 C--O 1.232 0.151 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.458 ' H ' ' HB2' ' B' ' 51' ' ' CYS . 7.3 m -89.44 113.41 24.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.568 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -75.55 153.26 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.982 -173.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -141.48 126.22 10.54 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.526 ' HA ' HD13 ' B' ' 46' ' ' ILE . 18.9 Cg_endo -59.21 124.34 15.39 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.065 1.843 . . . . 0.0 111.53 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' B' ' 45' ' ' CYS . 67.8 m -51.49 112.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.834 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 -0.3 78.23 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -105.88 -6.48 18.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.964 0.887 . . . . 0.0 109.228 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -104.13 168.41 9.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.843 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -159.98 147.06 16.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.28 -151.88 47.47 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.591 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.33 156.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.79 140.5 52.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.236 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.7 26.68 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.237 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 7.1 p30 -164.05 147.25 9.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.886 0.343 . . . . 0.0 110.539 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -103.18 -31.83 9.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.34 -52.3 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.44 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -59.04 -38.2 78.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -49.69 76.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.95 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.6 ttp180 -60.08 -53.1 61.72 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 12.7 t30 -53.26 -46.11 69.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.882 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.24 -48.92 79.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.412 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.593 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.9 m -55.89 -40.93 73.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.979 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 22.1 mm -56.08 -61.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.154 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 10.3 ptm180 -80.58 -42.66 21.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.249 -170.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 44.0 mt -86.52 -43.6 12.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.627 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -102.29 2.49 37.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.06 27.1 16.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.977 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -82.51 151.03 26.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.381 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -85.23 -29.82 24.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.011 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 86.5 t60 -142.66 160.73 39.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.56 155.35 26.55 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -160.8 170.81 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.094 0.473 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 19.4 t -103.35 75.78 1.37 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.434 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.696 HD22 HG13 ' B' ' 39' ' ' VAL . 0.1 OUTLIER -69.91 153.23 43.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.789 -172.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -100.63 85.47 2.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.696 HG13 HD22 ' B' ' 37' ' ' ASN . 1.8 m -82.75 98.03 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 74.5 t80 -44.51 134.29 4.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.433 -174.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 29.3 Cg_endo -100.44 30.17 11.82 Favored 'Cis proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.797 -1.335 . . . . 0.0 114.252 2.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.62 151.82 48.72 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' HIS . . . . . 0.518 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 32.5 m-70 -84.0 124.39 31.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.985 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -125.36 147.77 49.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.207 0.527 . . . . 0.0 110.355 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' B' ' 8' ' ' SER . 6.1 t -79.22 124.17 28.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 38.9 mm -128.06 119.31 50.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.671 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -88.44 145.65 25.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 82.8 m-85 -110.68 128.3 55.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.85 0.357 . . . . 0.0 111.007 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 138.44 27.05 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.937 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' B' ' 3' ' ' LEU . 62.0 Cg_exo -53.56 116.39 2.95 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 C-N-CA 123.133 2.556 . . . . 0.0 111.947 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' B' ' 4' ' ' CYS . 5.9 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.485 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 48' ' ' TYR . 26.9 mt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 m -104.21 126.76 51.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.717 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 0.7 OUTLIER -78.78 140.06 38.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.324 0.583 . . . . 0.0 111.302 -175.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 5' ' ' GLU . 14.2 mptt -133.68 128.47 19.96 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.192 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.48 129.37 26.4 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.82 1.68 . . . . 0.0 110.984 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -55.98 130.64 44.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.304 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.15 9.03 59.41 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.216 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.8 p -116.34 -25.73 7.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.281 0.562 . . . . 0.0 109.932 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -79.6 170.4 16.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.208 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -148.29 131.61 16.55 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.666 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.4 -141.7 32.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.031 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.43 145.52 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.12 144.81 35.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.37 -21.11 3.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.073 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.409 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 32.9 m-80 -123.79 125.0 43.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.426 0.155 . . . . 0.0 111.213 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.9 p-10 -77.71 -37.9 48.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 0.0 111.17 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.48 -38.32 21.44 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.57 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -63.78 -34.78 78.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 20.7 t -66.14 -47.9 72.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.926 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.645 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.1 ttp180 -54.75 -52.59 62.07 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -55.29 -47.57 75.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.054 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -62.46 -47.15 85.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.224 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 96.5 m -54.9 -39.72 69.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.952 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.645 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.7 mm -58.34 -65.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.514 0.674 . . . . 0.0 110.989 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.446 ' HG3' ' HG ' ' B' ' 28' ' ' LEU . 17.3 ptp180 -71.94 -43.26 65.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.083 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' B' ' 27' ' ' ARG . 69.1 mt -88.16 -42.68 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -172.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.21 -0.1 28.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' B' ' 30' ' ' LYS . 7.1 mtmp? 66.29 25.46 10.48 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.322 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -77.32 152.09 34.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.928 0.394 . . . . 0.0 110.85 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 32.6 mmm180 -82.45 -33.42 28.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.494 0.664 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -147.68 160.47 42.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -152.44 151.33 23.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.3 t -150.31 152.57 34.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.037 0.419 . . . . 0.0 110.087 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 18' ' ' ASN . 15.6 t -91.45 66.19 5.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.754 0.788 . . . . 0.0 109.09 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.92 157.02 35.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.464 -172.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.23 89.07 7.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.467 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.67 96.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 168.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -40.12 135.61 1.37 Allowed Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 123.823 0.702 . . . . 0.0 111.361 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -100.15 28.47 14.05 Favored 'Cis proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.956 -1.268 . . . . 0.0 114.065 3.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.42 33.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.0 111.956 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -77.27 127.2 32.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.908 173.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -123.08 145.84 48.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 42.6 t -73.75 106.51 5.52 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.913 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.717 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 31.1 mm -110.39 110.16 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.155 0.502 . . . . 0.0 110.653 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 46.0 m -79.06 148.51 32.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.407 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' B' ' 3' ' ' LEU . 74.4 m-85 -112.7 123.85 51.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.088 0.47 . . . . 0.0 111.437 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.452 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 95.6 m-85 -121.41 134.83 24.62 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.123 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 51.4 Cg_exo -51.5 125.16 15.94 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.85 2.367 . . . . 0.0 112.58 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.77 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.6 114.15 19.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.156 0.503 . . . . 0.0 109.753 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.649 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -68.38 153.07 44.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.262 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -142.47 125.94 9.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.163 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.496 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.5 Cg_endo -59.53 122.11 10.97 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.347 2.032 . . . . 0.0 111.742 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.4 p -49.49 128.97 18.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.483 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.92 5.67 42.93 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -114.39 -11.63 12.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.57 0.7 . . . . 0.0 110.257 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -92.41 171.1 9.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.876 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.8 m -154.49 139.25 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.602 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.51 -155.33 48.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.381 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.99 156.22 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 120.94 0.4 . . . . 0.0 110.075 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.22 147.35 40.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.446 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.71 22.76 2.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.821 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.2 p30 -158.17 137.19 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -88.6 -29.61 19.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.048 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.42 -56.68 2.77 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.683 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -58.55 -36.49 73.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.001 0.429 . . . . 0.0 109.928 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -61.44 -49.05 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.621 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.592 ' O ' HG12 ' B' ' 26' ' ' ILE . 35.9 ttm180 -63.44 -50.4 69.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 109.742 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -56.89 -43.18 81.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -58.7 -51.22 70.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.375 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 99.4 m -53.73 -40.58 66.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.186 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' B' ' 31' ' ' ALA . 19.0 mm -56.68 -58.33 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 121.375 0.607 . . . . 0.0 111.196 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' B' ' 27' ' ' ARG . 13.4 ptp180 -79.06 -45.84 19.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.925 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.88 -60.26 2.45 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.602 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.91 3.55 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 111.969 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 60.28 31.16 20.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -81.93 148.71 28.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.498 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -85.6 -25.61 26.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' HIS . . . . . 0.563 ' CE1' ' HD3' ' B' ' 22' ' ' ARG . 36.2 t60 -152.44 177.29 10.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.41 175.8 47.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.585 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 4.8 t -173.6 156.7 3.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 17.2 t -89.77 73.18 7.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.465 0.65 . . . . 0.0 109.258 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.453 ' OD1' HG13 ' B' ' 46' ' ' ILE . 0.1 OUTLIER -65.44 151.79 45.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.186 -172.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -92.08 81.47 5.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.353 0.597 . . . . 0.0 110.406 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.55 99.23 5.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 34.9 t80 -44.0 132.86 4.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.452 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 52.9 Cg_endo -101.21 23.36 17.43 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.13 -1.196 . . . . 0.0 114.205 2.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.12 41.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -90.58 125.33 35.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.865 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.52 151.74 50.67 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.094 0.473 . . . . 0.0 110.623 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -76.43 120.49 21.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.649 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 44.5 mm -123.24 116.67 49.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 35.9 m -86.02 136.86 33.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.879 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -101.12 123.33 45.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.863 0.363 . . . . 0.0 110.477 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 94.4 m-85 -116.27 138.46 24.29 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.686 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 13.4 Cg_exo -68.0 116.12 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.463 2.109 . . . . 0.0 111.781 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.364 177.312 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 50' ' ' PRO . 64.8 mt . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 120.741 0.305 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -112.98 118.06 33.77 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.617 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -67.7 152.36 45.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.848 -173.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -142.55 131.73 11.93 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.13 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.55 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.0 Cg_endo -58.16 129.58 33.69 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.245 1.964 . . . . 0.0 111.697 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 39.7 t -58.09 132.53 53.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 0.0 110.974 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.3 11.89 47.8 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -117.64 -20.66 8.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.573 0.702 . . . . 0.0 109.727 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -87.73 170.52 11.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.351 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.3 m -140.97 121.1 13.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.68 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.33 -152.03 51.54 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.746 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.72 148.4 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 8.0 p -110.62 146.88 35.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.762 0.315 . . . . 0.0 111.176 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.37 -7.36 34.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.332 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 42.8 m-80 -139.14 108.66 6.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.449 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -73.53 -31.47 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.744 0.307 . . . . 0.0 110.979 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.7 -38.87 22.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.337 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -62.09 -38.74 90.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.97 -49.29 78.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.652 ' O ' HG12 ' B' ' 26' ' ' ILE . 43.5 ttp180 -54.31 -55.95 23.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' B' ' 27' ' ' ARG . 40.8 t30 -53.62 -46.99 70.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.551 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -60.65 -48.21 82.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.398 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.1 m -54.69 -40.7 69.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.032 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.652 HG12 ' O ' ' B' ' 22' ' ' ARG . 14.7 mm -58.92 -58.76 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.762 0.791 . . . . 0.0 110.303 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 23' ' ' ASN . 70.7 mtp180 -71.29 -51.81 22.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.281 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.01 -26.88 18.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -115.36 4.95 14.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.972 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.13 29.19 18.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.594 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -83.82 157.57 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.992 0.425 . . . . 0.0 110.475 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -90.0 -26.65 20.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.827 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -153.49 168.56 25.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.11 160.94 34.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -176.1 160.14 2.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 43' ' ' HIS . 69.8 m -85.29 91.35 8.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -69.25 165.12 21.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -96.32 93.05 6.64 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.332 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -95.87 107.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.1 t80 -45.02 135.49 4.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.864 0.728 . . . . 0.0 111.572 -173.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.4 Cg_endo -100.07 21.61 21.01 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.807 -1.33 . . . . 0.0 113.508 1.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.9 178.81 6.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.353 0.596 . . . . 0.0 112.148 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 36' ' ' CYS . 55.0 m-70 -100.27 119.03 37.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.087 175.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -107.81 145.13 34.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -72.53 115.2 11.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.52 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.617 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 37.8 mm -124.89 128.17 73.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 -174.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.7 m -96.86 151.75 19.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.702 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -111.48 125.44 53.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.4 142.14 31.99 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.201 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' B' ' 3' ' ' LEU . 76.3 Cg_exo -53.15 118.2 4.57 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.04 2.493 . . . . 0.0 112.392 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.691 -178.347 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 50' ' ' PRO . 48.6 mt . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.701 0.286 . . . . 0.0 111.606 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 m -98.17 123.93 42.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.638 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -74.71 150.25 39.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.769 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.443 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 49.6 tttm -133.93 134.28 23.02 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.431 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.455 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.8 Cg_endo -62.03 130.66 31.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.672 1.581 . . . . 0.0 110.619 173.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -58.72 134.06 56.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.05 16.34 42.78 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -125.98 -26.57 3.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.056 0.455 . . . . 0.0 110.784 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -87.33 170.89 11.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.585 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -148.28 124.03 10.54 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.31 -162.81 54.31 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.78 144.12 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -92.53 167.54 11.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.801 0.334 . . . . 0.0 110.225 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.35 -11.25 10.81 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.891 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 43.5 m-80 -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.46 -41.43 76.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.26 58.91 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.594 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.41 -38.73 92.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.74 -46.85 80.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.111 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.631 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.0 ttp180 -60.94 -52.41 65.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.839 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 40.0 t30 -53.48 -46.18 69.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.519 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.16 -48.45 81.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 82.3 m -54.64 -43.24 72.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.643 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.631 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.5 mm -55.93 -55.54 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.399 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 23.2 mmt180 -74.74 -63.72 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.565 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.23 -48.79 26.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.836 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.68 -0.2 57.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 59.69 38.59 21.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.06 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -88.69 150.82 22.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -83.54 -25.32 31.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -153.14 167.3 29.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.353 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.3 162.34 35.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 88.0 p -159.6 145.16 15.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.829 0.315 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 6.8 t -82.33 76.18 9.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 152.46 45.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.298 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -90.56 77.08 6.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.685 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.27 101.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 56.2 t80 -43.31 135.13 3.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.393 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 42.3 Cg_endo -101.22 25.94 15.45 Favored 'Cis proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.575 4.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 163.83 31.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' HIS . . . . . 0.452 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 42.8 m-70 -89.75 117.71 28.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.55 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -119.51 154.83 33.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.14 0.495 . . . . 0.0 110.53 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.36 110.48 10.92 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.249 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 43.2 mm -118.84 116.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 m -86.89 153.37 21.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.12 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.37 130.52 56.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.956 0.408 . . . . 0.0 111.066 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.1 m-85 -126.42 142.19 42.23 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.167 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.437 ' HA ' HD23 ' B' ' 3' ' ' LEU . 77.3 Cg_exo -52.16 118.97 5.08 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.803 2.335 . . . . 0.0 111.827 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.44 -177.253 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.038 0.446 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 72.1 m -117.05 116.85 28.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.461 0.648 . . . . 0.0 110.583 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.658 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.5 mp0 -74.72 149.51 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.902 -171.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.69 125.55 11.94 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.538 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.459 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.8 Cg_endo -53.71 125.45 18.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.626 2.218 . . . . 0.0 112.477 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -59.15 139.48 56.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.86 13.56 26.93 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -119.93 8.59 11.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.578 0.704 . . . . 0.0 109.898 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -124.45 172.25 9.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.538 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -167.56 158.03 11.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 -164.31 54.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.321 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -83.85 128.74 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 t -81.3 133.28 35.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -29.25 4.12 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.914 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -126.84 114.94 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 111.26 -168.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.3 p-10 -72.94 -32.8 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.95 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.52 -52.05 23.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.579 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.32 -37.67 72.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.9 t -61.5 -47.5 85.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.51 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.66 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.9 ttp85 -62.04 -49.51 75.7 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -59.33 -43.77 92.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.549 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -58.19 -45.75 86.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.771 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 87.2 m -60.23 -41.13 92.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.824 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.66 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.9 mm -58.33 -58.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.464 0.65 . . . . 0.0 110.642 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -73.79 -61.37 1.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.666 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 mt -74.46 -40.43 61.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.988 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -107.87 5.27 26.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.989 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt 56.75 32.86 21.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.965 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -80.99 149.56 29.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.627 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -77.85 -30.94 51.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.071 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -151.8 167.6 27.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.952 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.408 ' N ' ' HG3' ' B' ' 22' ' ' ARG . . . -161.33 165.05 35.3 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -160.58 155.44 24.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.974 0.387 . . . . 0.0 110.121 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 26.2 t -91.44 72.23 6.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 153.6 31.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.598 -172.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -96.54 79.55 3.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.857 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.2 101.25 4.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -46.35 134.73 7.42 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.703 -171.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -102.08 28.04 12.24 Favored 'Cis proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.049 -1.23 . . . . 0.0 113.849 2.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.0 170.81 15.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 112.13 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' HIS . . . . . 0.636 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 51.4 m-70 -100.01 130.16 46.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -127.65 148.47 50.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.267 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 35.4 t -74.21 117.33 15.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.658 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 36.1 mm -126.63 119.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.455 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 37.5 m -84.21 151.23 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.33 121.78 45.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.086 0.469 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.37 135.32 24.92 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.236 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.88 117.85 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.283 1.989 . . . . 0.0 112.178 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' B' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.318 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.113 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.097 0.475 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 36.4 m -120.38 125.74 48.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.02 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.67 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.9 mp0 -76.89 139.09 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.401 0.62 . . . . 0.0 111.483 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' HD2' ' B' ' 49' ' ' PHE . 2.1 mptm? -132.46 141.46 41.33 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.211 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.33 138.46 60.78 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.06 1.84 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.9 p -59.76 131.79 51.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.371 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.08 14.61 33.79 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.488 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.8 p -131.85 -9.42 3.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' TRP . . . . . 0.517 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 19.4 t-105 -104.86 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.321 0.582 . . . . 0.0 110.376 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' B' ' 11' ' ' TRP . 26.9 m -89.7 -155.97 0.39 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.768 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.61 -116.14 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.242 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.57 147.74 6.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.487 . . . . 0.0 111.347 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 6.5 p -130.64 147.93 52.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.227 0.537 . . . . 0.0 110.929 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.64 -45.48 6.41 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.246 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 40.9 m-80 -116.51 126.98 54.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.765 0.317 . . . . 0.0 110.792 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -70.38 -28.08 64.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.65 -34.42 25.15 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.751 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -64.98 -38.58 91.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -61.5 -49.24 77.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.792 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.634 ' O ' HG12 ' B' ' 26' ' ' ILE . 50.1 ttp180 -52.5 -55.3 22.96 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.155 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -51.96 -48.58 64.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.903 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -64.0 -44.71 91.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 74.6 m -55.56 -41.12 72.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.453 174.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.634 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.1 mm -56.97 -59.14 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.47 0.653 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -80.69 -51.02 9.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.345 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -79.36 -42.92 24.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.75 1.46 37.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' B' ' 26' ' ' ILE . 34.7 mmtp 57.81 29.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.885 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -78.26 151.35 33.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.985 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' B' ' 32' ' ' ARG . 4.3 mmp_? -83.11 -24.93 32.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -153.56 167.01 30.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.482 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.34 158.64 31.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.3 m -162.18 151.99 16.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.074 0.437 . . . . 0.0 110.539 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -76.38 81.83 3.12 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.203 0.525 . . . . 0.0 109.986 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.17 156.98 29.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.98 83.2 7.85 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.835 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 95.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 167.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 82.7 t80 -44.26 135.04 4.26 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.628 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 31.8 Cg_endo -100.03 29.92 12.44 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.874 -1.302 . . . . 0.0 113.807 1.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.33 167.49 21.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.324 0.583 . . . . 0.0 112.052 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.37 111.07 22.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.827 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -105.75 147.39 28.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.722 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.5 t -73.6 114.98 12.47 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 30.1 mm -121.13 118.52 56.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.112 0.482 . . . . 0.0 110.887 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.6 m -84.78 148.3 26.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.817 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.01 121.5 45.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.922 0.391 . . . . 0.0 110.916 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 98.0 m-85 -117.87 138.56 25.47 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.341 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.85 123.15 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.645 2.23 . . . . 0.0 111.982 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.859 178.141 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 50' ' ' PRO . 67.0 mt . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.8 m -110.75 122.72 48.52 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -75.55 152.39 37.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.429 0.633 . . . . 0.0 112.035 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.441 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 64.2 tttp -137.79 131.32 16.95 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.436 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.9 Cg_endo -60.53 124.91 16.04 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.117 1.878 . . . . 0.0 111.203 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -51.91 133.45 32.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' B' ' 29' ' ' GLU . . . -102.17 3.78 51.61 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -115.13 -20.45 10.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -90.63 167.06 12.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.012 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -158.25 151.02 22.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.737 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.83 -149.64 45.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.939 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.18 139.65 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 120.815 0.341 . . . . 0.0 110.603 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.0 t -104.28 148.32 26.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.144 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.62 32.25 1.22 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.576 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.8 p30 -165.06 129.79 2.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -89.25 -30.8 18.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.706 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.84 -49.8 5.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.219 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -61.27 -47.93 83.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.269 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.588 ' O ' HG12 ' B' ' 26' ' ' ILE . 55.5 ttp180 -60.75 -51.32 69.85 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.121 0.486 . . . . 0.0 109.746 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -55.08 -48.69 73.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.176 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.408 ' CG ' HD12 ' B' ' 28' ' ' LEU . 17.0 tt0 -60.51 -45.04 95.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 98.8 m -56.17 -42.76 77.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.588 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.8 mm -54.88 -56.72 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.746 0.784 . . . . 0.0 111.004 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.88 -63.6 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.828 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CG ' ' B' ' 24' ' ' GLN . 83.0 mt -72.18 -35.75 69.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.684 -170.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' B' ' 9' ' ' GLY . 35.2 mt-10 -108.46 3.4 23.15 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.929 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp 58.67 34.32 23.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.041 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -86.77 154.61 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.333 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -90.1 -22.38 21.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.24 166.27 33.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.02 161.73 31.72 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -152.62 144.77 23.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.807 0.304 . . . . 0.0 110.666 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 35.8 t -90.43 79.94 6.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.465 ' ND2' HG13 ' B' ' 46' ' ' ILE . 23.1 p-10 -71.07 167.78 18.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.316 -171.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -110.62 77.37 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.075 0.464 . . . . 0.0 110.273 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.52 102.1 6.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 55.9 t80 -43.22 137.2 2.85 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.173 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 44.1 Cg_endo -99.86 24.54 18.7 Favored 'Cis proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.155 -1.185 . . . . 0.0 114.694 3.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.92 163.4 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 112.241 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 54.9 m-70 -86.24 128.12 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.303 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -118.01 168.88 10.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.166 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.02 116.08 28.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.678 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 45.8 mm -115.98 117.15 54.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.534 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.01 145.48 27.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' B' ' 3' ' ' LEU . 3.5 m-85 -110.02 122.53 47.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.923 0.392 . . . . 0.0 110.766 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.0 m-85 -116.5 139.19 25.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.874 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HA ' HD23 ' B' ' 3' ' ' LEU . 53.4 Cg_exo -53.14 115.68 2.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.811 2.341 . . . . 0.0 111.656 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.263 -174.308 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 50' ' ' PRO . 52.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 99.0 m -109.17 129.0 55.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.597 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.0 OUTLIER -84.19 147.91 27.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.491 0.662 . . . . 0.0 112.019 -170.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -136.29 126.4 16.25 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.679 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.565 ' HA ' HD13 ' B' ' 46' ' ' ILE . 26.9 Cg_exo -60.45 133.68 50.44 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.069 1.846 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 79.2 p -53.08 127.77 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.565 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.89 4.07 56.01 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.4 p -120.17 -0.88 10.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.48 0.657 . . . . 0.0 110.334 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' TRP . . . . . 0.46 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 6.3 t-105 -126.21 169.83 12.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -160.66 133.31 6.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.24 -165.67 34.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.942 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.99 120.32 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.057 0.456 . . . . 0.0 110.003 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 3.3 p -88.85 135.65 33.42 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.95 38.57 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.815 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 41.6 m-80 -122.01 120.89 35.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.805 0.336 . . . . 0.0 110.553 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -66.67 -31.18 71.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.693 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.74 -36.45 37.18 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.49 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.79 -38.51 91.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -59.93 -47.25 86.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.72 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.671 ' O ' HG12 ' B' ' 26' ' ' ILE . 38.9 ttt180 -58.95 -52.13 67.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -58.42 -36.51 73.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.321 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 -43.8 73.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 72.7 m -58.73 -40.19 83.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.596 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.671 HG12 ' O ' ' B' ' 22' ' ' ARG . 26.8 mm -54.61 -60.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.71 0.767 . . . . 0.0 110.756 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -69.02 -61.9 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.757 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -79.95 -43.24 22.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.223 -168.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.57 1.2 40.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.939 -172.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 58.9 36.0 24.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.968 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -88.35 151.12 22.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -83.73 -33.43 25.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' HIS . . . . . 0.534 ' CE1' ' HD2' ' B' ' 22' ' ' ARG . 73.5 t60 -139.66 166.48 24.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -161.95 156.4 27.94 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -170.14 154.03 4.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.199 0.499 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' B' ' 44' ' ' LYS . 84.1 m -84.89 81.44 8.89 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.521 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -61.97 160.64 11.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.675 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -98.56 85.24 3.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 111.497 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.78 104.61 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.7 t80 -46.65 135.55 7.78 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.365 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.9 Cg_endo -99.59 21.37 22.27 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.962 -1.266 . . . . 0.0 113.417 0.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.5 -175.51 3.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.275 0.559 . . . . 0.0 111.834 -172.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -114.98 133.41 56.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.092 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 36' ' ' CYS . 40.0 mmtm -123.53 148.98 45.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.287 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.62 120.54 20.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.209 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.597 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 32.6 mm -127.11 119.72 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 25.4 m -86.68 142.57 28.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.487 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 85.0 m-85 -110.58 122.57 48.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.042 0.448 . . . . 0.0 111.048 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 90.7 m-85 -113.91 135.31 22.04 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.484 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 38.4 Cg_exo -59.4 125.04 16.84 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.042 2.495 . . . . 0.0 113.072 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.298 -0.858 . . . . 0.0 109.953 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -93.03 120.35 33.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.954 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 7.9 mp0 -81.98 136.48 35.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.946 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -131.01 123.85 20.19 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.408 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.6 Cg_endo -53.55 125.99 20.33 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.544 2.163 . . . . 0.0 111.909 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -55.82 143.66 30.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.285 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.91 10.87 20.79 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.189 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -118.44 -19.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' B' ' 15' ' ' CYS . 7.3 t-105 -98.66 171.77 7.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.987 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.0 p -157.17 129.02 7.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 -148.27 39.49 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.674 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 142.31 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 120.919 0.39 . . . . 0.0 110.347 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.484 ' HA ' ' NE1' ' B' ' 11' ' ' TRP . 15.6 p -96.03 170.68 9.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.03 -62.79 2.28 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.592 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -154.22 167.19 30.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -54.37 -50.47 67.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.41 0.444 . . . . 0.0 111.852 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.32 -36.22 78.09 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.243 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.26 78.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.155 0.503 . . . . 0.0 109.795 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' B' ' 36' ' ' CYS . 25.3 t -69.18 -46.65 66.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.825 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 42.9 ttp180 -56.64 -54.4 46.47 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.953 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -61.98 -48.71 79.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.159 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -54.9 -41.09 70.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.027 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 18.5 mm -56.09 -60.15 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.772 0.796 . . . . 0.0 110.475 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 27' ' ' ARG . 42.0 mtm180 -72.95 -56.17 5.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.88 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.64 -32.56 31.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.795 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -112.47 6.48 18.59 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.609 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 55.35 35.23 24.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.431 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -84.21 153.47 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.852 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -88.03 -28.2 21.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 0.0 110.778 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -148.81 171.12 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.49 156.75 26.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.6 m -161.56 134.85 6.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' B' ' 21' ' ' CYS . 97.4 m -67.04 139.0 57.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.958 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' B' ' 43' ' ' HIS . 36.0 p-10 -117.6 169.86 9.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.202 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.79 64.32 0.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.244 0.545 . . . . 0.0 110.248 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.76 92.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 167.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 81.5 t80 -46.47 138.15 6.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.851 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.3 Cg_endo -100.26 29.62 12.59 Favored 'Cis proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.143 -1.191 . . . . 0.0 114.758 4.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.73 151.02 46.77 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.418 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 9.2 m-70 -89.96 91.99 8.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.875 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.33 174.02 11.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.005 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 45.4 t -100.1 116.47 32.2 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.079 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.662 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 35.4 mm -116.08 116.51 52.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.056 0.455 . . . . 0.0 110.427 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 m -83.38 149.83 26.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.054 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.29 125.07 53.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.058 0.456 . . . . 0.0 111.032 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.56 139.69 28.24 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.545 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.19 124.82 17.19 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.807 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.127 178.126 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.413 0.149 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -74.86 -168.41 0.73 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.389 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' B' ' 50' ' ' PRO . 19.9 mt -52.37 134.64 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.293 172.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.458 ' H ' ' HB2' ' B' ' 51' ' ' CYS . 7.3 m -89.44 113.41 24.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.568 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -75.55 153.26 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.982 -173.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -141.48 126.22 10.54 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.526 ' HA ' HD13 ' B' ' 46' ' ' ILE . 18.9 Cg_endo -59.21 124.34 15.39 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.065 1.843 . . . . 0.0 111.53 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' B' ' 45' ' ' CYS . 67.8 m -51.49 112.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.834 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 -0.3 78.23 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -105.88 -6.48 18.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.964 0.887 . . . . 0.0 109.228 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -104.13 168.41 9.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.843 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -159.98 147.06 16.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.28 -151.88 47.47 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.591 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.33 156.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.79 140.5 52.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.236 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.7 26.68 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.237 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 7.1 p30 -164.05 147.25 9.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.886 0.343 . . . . 0.0 110.539 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -103.18 -31.83 9.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.34 -52.3 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.44 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -59.04 -38.2 78.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -49.69 76.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.95 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.6 ttp180 -60.08 -53.1 61.72 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 12.7 t30 -53.26 -46.11 69.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.882 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.24 -48.92 79.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.412 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.593 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.9 m -55.89 -40.93 73.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.979 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 22.1 mm -56.08 -61.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.154 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 10.3 ptm180 -80.58 -42.66 21.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.249 -170.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 44.0 mt -86.52 -43.6 12.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.627 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -102.29 2.49 37.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.06 27.1 16.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.977 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -82.51 151.03 26.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.381 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -85.23 -29.82 24.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.011 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 86.5 t60 -142.66 160.73 39.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.56 155.35 26.55 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -160.8 170.81 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.094 0.473 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 19.4 t -103.35 75.78 1.37 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.434 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.696 HD22 HG13 ' B' ' 39' ' ' VAL . 0.1 OUTLIER -69.91 153.23 43.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.789 -172.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -100.63 85.47 2.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.696 HG13 HD22 ' B' ' 37' ' ' ASN . 1.8 m -82.75 98.03 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 74.5 t80 -44.51 134.29 4.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.433 -174.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 29.3 Cg_endo -100.44 30.17 11.82 Favored 'Cis proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.797 -1.335 . . . . 0.0 114.252 2.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.62 151.82 48.72 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' HIS . . . . . 0.518 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 32.5 m-70 -84.0 124.39 31.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.985 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -125.36 147.77 49.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.207 0.527 . . . . 0.0 110.355 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' B' ' 8' ' ' SER . 6.1 t -79.22 124.17 28.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 38.9 mm -128.06 119.31 50.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.671 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -88.44 145.65 25.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 82.8 m-85 -110.68 128.3 55.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.85 0.357 . . . . 0.0 111.007 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 138.44 27.05 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.937 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' B' ' 3' ' ' LEU . 62.0 Cg_exo -53.56 116.39 2.95 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 C-N-CA 123.133 2.556 . . . . 0.0 111.947 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' B' ' 4' ' ' CYS . 5.9 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.485 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.03 0.443 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -89.03 -163.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.501 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 48' ' ' TYR . 26.9 mt -68.14 154.64 41.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.16 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 m -104.21 126.76 51.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.717 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 0.7 OUTLIER -78.78 140.06 38.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.324 0.583 . . . . 0.0 111.302 -175.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 5' ' ' GLU . 14.2 mptt -133.68 128.47 19.96 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.192 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.48 129.37 26.4 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.82 1.68 . . . . 0.0 110.984 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -55.98 130.64 44.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.304 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.15 9.03 59.41 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.216 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.8 p -116.34 -25.73 7.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.281 0.562 . . . . 0.0 109.932 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -79.6 170.4 16.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.208 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -148.29 131.61 16.55 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.666 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.4 -141.7 32.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.031 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.43 145.52 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.12 144.81 35.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.37 -21.11 3.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.073 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.409 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 32.9 m-80 -123.79 125.0 43.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.426 0.155 . . . . 0.0 111.213 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.9 p-10 -77.71 -37.9 48.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 0.0 111.17 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.48 -38.32 21.44 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.57 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -63.78 -34.78 78.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 20.7 t -66.14 -47.9 72.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.926 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.645 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.1 ttp180 -54.75 -52.59 62.07 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -55.29 -47.57 75.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.054 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -62.46 -47.15 85.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.224 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 96.5 m -54.9 -39.72 69.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.952 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.645 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.7 mm -58.34 -65.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.514 0.674 . . . . 0.0 110.989 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.446 ' HG3' ' HG ' ' B' ' 28' ' ' LEU . 17.3 ptp180 -71.94 -43.26 65.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.083 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' B' ' 27' ' ' ARG . 69.1 mt -88.16 -42.68 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -172.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.21 -0.1 28.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' B' ' 30' ' ' LYS . 7.1 mtmp? 66.29 25.46 10.48 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.322 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -77.32 152.09 34.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.928 0.394 . . . . 0.0 110.85 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 32.6 mmm180 -82.45 -33.42 28.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.494 0.664 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -147.68 160.47 42.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -152.44 151.33 23.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.3 t -150.31 152.57 34.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.037 0.419 . . . . 0.0 110.087 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 18' ' ' ASN . 15.6 t -91.45 66.19 5.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.754 0.788 . . . . 0.0 109.09 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.92 157.02 35.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.464 -172.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.23 89.07 7.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.467 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.67 96.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 168.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -40.12 135.61 1.37 Allowed Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 123.823 0.702 . . . . 0.0 111.361 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -100.15 28.47 14.05 Favored 'Cis proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.956 -1.268 . . . . 0.0 114.065 3.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.42 33.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.0 111.956 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -77.27 127.2 32.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.908 173.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -123.08 145.84 48.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 42.6 t -73.75 106.51 5.52 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.913 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.717 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 31.1 mm -110.39 110.16 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.155 0.502 . . . . 0.0 110.653 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 46.0 m -79.06 148.51 32.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.407 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' B' ' 3' ' ' LEU . 74.4 m-85 -112.7 123.85 51.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.088 0.47 . . . . 0.0 111.437 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.452 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 95.6 m-85 -121.41 134.83 24.62 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.123 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 51.4 Cg_exo -51.5 125.16 15.94 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.85 2.367 . . . . 0.0 112.58 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.77 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -76.52 96.11 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.958 0.885 . . . . 0.0 110.097 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.48 154.21 50.13 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.44 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.6 114.15 19.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.156 0.503 . . . . 0.0 109.753 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.649 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -68.38 153.07 44.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.262 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -142.47 125.94 9.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.163 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.496 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.5 Cg_endo -59.53 122.11 10.97 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.347 2.032 . . . . 0.0 111.742 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.4 p -49.49 128.97 18.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.483 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.92 5.67 42.93 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -114.39 -11.63 12.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.57 0.7 . . . . 0.0 110.257 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -92.41 171.1 9.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.876 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.8 m -154.49 139.25 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.602 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.51 -155.33 48.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.381 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.99 156.22 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 120.94 0.4 . . . . 0.0 110.075 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.22 147.35 40.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.446 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.71 22.76 2.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.821 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.2 p30 -158.17 137.19 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -88.6 -29.61 19.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.048 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.42 -56.68 2.77 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.683 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -58.55 -36.49 73.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.001 0.429 . . . . 0.0 109.928 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -61.44 -49.05 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.621 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.592 ' O ' HG12 ' B' ' 26' ' ' ILE . 35.9 ttm180 -63.44 -50.4 69.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 109.742 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -56.89 -43.18 81.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -58.7 -51.22 70.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.375 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 99.4 m -53.73 -40.58 66.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.186 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' B' ' 31' ' ' ALA . 19.0 mm -56.68 -58.33 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 121.375 0.607 . . . . 0.0 111.196 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' B' ' 27' ' ' ARG . 13.4 ptp180 -79.06 -45.84 19.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.925 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.88 -60.26 2.45 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.602 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.91 3.55 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 111.969 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 60.28 31.16 20.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -81.93 148.71 28.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.498 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -85.6 -25.61 26.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' HIS . . . . . 0.563 ' CE1' ' HD3' ' B' ' 22' ' ' ARG . 36.2 t60 -152.44 177.29 10.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.41 175.8 47.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.585 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 4.8 t -173.6 156.7 3.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 17.2 t -89.77 73.18 7.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.465 0.65 . . . . 0.0 109.258 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.453 ' OD1' HG13 ' B' ' 46' ' ' ILE . 0.1 OUTLIER -65.44 151.79 45.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.186 -172.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -92.08 81.47 5.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.353 0.597 . . . . 0.0 110.406 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.55 99.23 5.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 34.9 t80 -44.0 132.86 4.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.452 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 52.9 Cg_endo -101.21 23.36 17.43 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.13 -1.196 . . . . 0.0 114.205 2.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.12 41.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -90.58 125.33 35.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.865 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.52 151.74 50.67 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.094 0.473 . . . . 0.0 110.623 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -76.43 120.49 21.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.649 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 44.5 mm -123.24 116.67 49.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 35.9 m -86.02 136.86 33.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.879 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -101.12 123.33 45.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.863 0.363 . . . . 0.0 110.477 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 94.4 m-85 -116.27 138.46 24.29 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.686 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 13.4 Cg_exo -68.0 116.12 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.463 2.109 . . . . 0.0 111.781 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.364 177.312 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.42 ' HG3' ' H ' ' B' ' 2' ' ' ARG . 0.0 OUTLIER -85.15 41.18 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 111.24 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 50' ' ' PRO . 64.8 mt -127.09 136.16 51.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.553 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -112.98 118.06 33.77 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.617 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -67.7 152.36 45.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.848 -173.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -142.55 131.73 11.93 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.13 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.55 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.0 Cg_endo -58.16 129.58 33.69 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.245 1.964 . . . . 0.0 111.697 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 39.7 t -58.09 132.53 53.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 0.0 110.974 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.3 11.89 47.8 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -117.64 -20.66 8.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.573 0.702 . . . . 0.0 109.727 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -87.73 170.52 11.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.351 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.3 m -140.97 121.1 13.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.68 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.33 -152.03 51.54 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.746 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.72 148.4 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 8.0 p -110.62 146.88 35.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.762 0.315 . . . . 0.0 111.176 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.37 -7.36 34.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.332 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 42.8 m-80 -139.14 108.66 6.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.449 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -73.53 -31.47 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.744 0.307 . . . . 0.0 110.979 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.7 -38.87 22.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.337 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -62.09 -38.74 90.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.97 -49.29 78.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.652 ' O ' HG12 ' B' ' 26' ' ' ILE . 43.5 ttp180 -54.31 -55.95 23.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' B' ' 27' ' ' ARG . 40.8 t30 -53.62 -46.99 70.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.551 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -60.65 -48.21 82.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.398 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.1 m -54.69 -40.7 69.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.032 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.652 HG12 ' O ' ' B' ' 22' ' ' ARG . 14.7 mm -58.92 -58.76 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.762 0.791 . . . . 0.0 110.303 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 23' ' ' ASN . 70.7 mtp180 -71.29 -51.81 22.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.281 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.01 -26.88 18.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -115.36 4.95 14.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.972 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.13 29.19 18.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.594 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -83.82 157.57 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.992 0.425 . . . . 0.0 110.475 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -90.0 -26.65 20.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.827 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -153.49 168.56 25.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.11 160.94 34.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -176.1 160.14 2.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 43' ' ' HIS . 69.8 m -85.29 91.35 8.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -69.25 165.12 21.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -96.32 93.05 6.64 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.332 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -95.87 107.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.1 t80 -45.02 135.49 4.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.864 0.728 . . . . 0.0 111.572 -173.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.4 Cg_endo -100.07 21.61 21.01 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.807 -1.33 . . . . 0.0 113.508 1.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.9 178.81 6.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.353 0.596 . . . . 0.0 112.148 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 36' ' ' CYS . 55.0 m-70 -100.27 119.03 37.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.087 175.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -107.81 145.13 34.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -72.53 115.2 11.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.52 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.617 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 37.8 mm -124.89 128.17 73.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 -174.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.7 m -96.86 151.75 19.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.702 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -111.48 125.44 53.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.4 142.14 31.99 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.201 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' B' ' 3' ' ' LEU . 76.3 Cg_exo -53.15 118.2 4.57 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.04 2.493 . . . . 0.0 112.392 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.691 -178.347 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.94 0.4 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -90.53 -166.56 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.16 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 50' ' ' PRO . 48.6 mt -44.42 132.47 6.02 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.758 0.662 . . . . 0.0 111.606 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 m -98.17 123.93 42.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.638 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -74.71 150.25 39.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.769 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.443 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 49.6 tttm -133.93 134.28 23.02 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.431 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.455 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.8 Cg_endo -62.03 130.66 31.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.672 1.581 . . . . 0.0 110.619 173.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -58.72 134.06 56.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.05 16.34 42.78 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -125.98 -26.57 3.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.056 0.455 . . . . 0.0 110.784 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -87.33 170.89 11.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.585 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -148.28 124.03 10.54 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.31 -162.81 54.31 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.78 144.12 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -92.53 167.54 11.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.801 0.334 . . . . 0.0 110.225 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.35 -11.25 10.81 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.891 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 43.5 m-80 -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.46 -41.43 76.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.26 58.91 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.594 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.41 -38.73 92.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.74 -46.85 80.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.111 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.631 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.0 ttp180 -60.94 -52.41 65.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.839 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 40.0 t30 -53.48 -46.18 69.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.519 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -59.16 -48.45 81.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 82.3 m -54.64 -43.24 72.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.643 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.631 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.5 mm -55.93 -55.54 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.399 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 23.2 mmt180 -74.74 -63.72 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.565 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.23 -48.79 26.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.836 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.68 -0.2 57.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 59.69 38.59 21.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.06 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -88.69 150.82 22.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -83.54 -25.32 31.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -153.14 167.3 29.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.353 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.3 162.34 35.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 88.0 p -159.6 145.16 15.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.829 0.315 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 6.8 t -82.33 76.18 9.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 152.46 45.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.298 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -90.56 77.08 6.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.685 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.27 101.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 56.2 t80 -43.31 135.13 3.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.393 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 42.3 Cg_endo -101.22 25.94 15.45 Favored 'Cis proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.575 4.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 163.83 31.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' HIS . . . . . 0.452 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 42.8 m-70 -89.75 117.71 28.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.55 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -119.51 154.83 33.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.14 0.495 . . . . 0.0 110.53 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.36 110.48 10.92 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.249 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 43.2 mm -118.84 116.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 m -86.89 153.37 21.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.12 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.37 130.52 56.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.956 0.408 . . . . 0.0 111.066 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.1 m-85 -126.42 142.19 42.23 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.167 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.437 ' HA ' HD23 ' B' ' 3' ' ' LEU . 77.3 Cg_exo -52.16 118.97 5.08 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.803 2.335 . . . . 0.0 111.827 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.44 -177.253 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.478 0.18 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 3' ' ' LEU . 30.1 ptt180 -82.67 -170.03 2.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' B' ' 2' ' ' ARG . 33.4 mt -54.7 160.64 1.78 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.446 . . . . 0.0 110.803 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 72.1 m -117.05 116.85 28.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.461 0.648 . . . . 0.0 110.583 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.658 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.5 mp0 -74.72 149.51 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.902 -171.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.69 125.55 11.94 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.538 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.459 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.8 Cg_endo -53.71 125.45 18.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.626 2.218 . . . . 0.0 112.477 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -59.15 139.48 56.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.86 13.56 26.93 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -119.93 8.59 11.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.578 0.704 . . . . 0.0 109.898 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -124.45 172.25 9.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.538 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -167.56 158.03 11.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 -164.31 54.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.321 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -83.85 128.74 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 t -81.3 133.28 35.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -29.25 4.12 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.914 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -126.84 114.94 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 111.26 -168.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.3 p-10 -72.94 -32.8 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.95 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.52 -52.05 23.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.579 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.32 -37.67 72.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.9 t -61.5 -47.5 85.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.51 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.66 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.9 ttp85 -62.04 -49.51 75.7 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -59.33 -43.77 92.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.549 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -58.19 -45.75 86.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.771 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 87.2 m -60.23 -41.13 92.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.824 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.66 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.9 mm -58.33 -58.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.464 0.65 . . . . 0.0 110.642 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -73.79 -61.37 1.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.666 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 mt -74.46 -40.43 61.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.988 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -107.87 5.27 26.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.989 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt 56.75 32.86 21.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.965 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -80.99 149.56 29.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.627 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -77.85 -30.94 51.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.071 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -151.8 167.6 27.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.952 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.408 ' N ' ' HG3' ' B' ' 22' ' ' ARG . . . -161.33 165.05 35.3 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -160.58 155.44 24.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.974 0.387 . . . . 0.0 110.121 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 26.2 t -91.44 72.23 6.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 153.6 31.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.598 -172.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -96.54 79.55 3.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.857 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.2 101.25 4.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -46.35 134.73 7.42 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.703 -171.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -102.08 28.04 12.24 Favored 'Cis proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.049 -1.23 . . . . 0.0 113.849 2.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.0 170.81 15.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 112.13 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' HIS . . . . . 0.636 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 51.4 m-70 -100.01 130.16 46.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -127.65 148.47 50.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.267 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 35.4 t -74.21 117.33 15.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.658 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 36.1 mm -126.63 119.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.455 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 37.5 m -84.21 151.23 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.33 121.78 45.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.086 0.469 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.37 135.32 24.92 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.236 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.88 117.85 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.283 1.989 . . . . 0.0 112.178 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' B' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.318 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.113 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.937 0.399 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -99.8 -163.1 1.0 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.394 . . . . 0.0 110.374 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.0 164.63 25.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.897 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 36.4 m -120.38 125.74 48.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.02 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.67 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.9 mp0 -76.89 139.09 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.401 0.62 . . . . 0.0 111.483 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' HD2' ' B' ' 49' ' ' PHE . 2.1 mptm? -132.46 141.46 41.33 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.211 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.33 138.46 60.78 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.06 1.84 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.9 p -59.76 131.79 51.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.371 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.08 14.61 33.79 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.488 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.8 p -131.85 -9.42 3.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' TRP . . . . . 0.517 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 19.4 t-105 -104.86 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.321 0.582 . . . . 0.0 110.376 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' B' ' 11' ' ' TRP . 26.9 m -89.7 -155.97 0.39 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.768 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.61 -116.14 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.242 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.57 147.74 6.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.487 . . . . 0.0 111.347 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 6.5 p -130.64 147.93 52.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.227 0.537 . . . . 0.0 110.929 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.64 -45.48 6.41 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.246 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 40.9 m-80 -116.51 126.98 54.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.765 0.317 . . . . 0.0 110.792 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -70.38 -28.08 64.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.65 -34.42 25.15 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.751 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -64.98 -38.58 91.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -61.5 -49.24 77.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.792 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.634 ' O ' HG12 ' B' ' 26' ' ' ILE . 50.1 ttp180 -52.5 -55.3 22.96 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.155 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -51.96 -48.58 64.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.903 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -64.0 -44.71 91.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 74.6 m -55.56 -41.12 72.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.453 174.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.634 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.1 mm -56.97 -59.14 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.47 0.653 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -80.69 -51.02 9.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.345 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -79.36 -42.92 24.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.75 1.46 37.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' B' ' 26' ' ' ILE . 34.7 mmtp 57.81 29.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.885 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -78.26 151.35 33.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.985 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' B' ' 32' ' ' ARG . 4.3 mmp_? -83.11 -24.93 32.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -153.56 167.01 30.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.482 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.34 158.64 31.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.3 m -162.18 151.99 16.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.074 0.437 . . . . 0.0 110.539 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -76.38 81.83 3.12 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.203 0.525 . . . . 0.0 109.986 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.17 156.98 29.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.98 83.2 7.85 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.835 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 95.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 167.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 82.7 t80 -44.26 135.04 4.26 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.628 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 31.8 Cg_endo -100.03 29.92 12.44 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.874 -1.302 . . . . 0.0 113.807 1.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.33 167.49 21.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.324 0.583 . . . . 0.0 112.052 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.37 111.07 22.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.827 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -105.75 147.39 28.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.722 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.5 t -73.6 114.98 12.47 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 30.1 mm -121.13 118.52 56.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.112 0.482 . . . . 0.0 110.887 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.6 m -84.78 148.3 26.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.817 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.01 121.5 45.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.922 0.391 . . . . 0.0 110.916 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 98.0 m-85 -117.87 138.56 25.47 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.341 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.85 123.15 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.645 2.23 . . . . 0.0 111.982 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.859 178.141 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -80.69 46.69 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.53 0.681 . . . . 0.0 110.5 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 50' ' ' PRO . 67.0 mt -125.84 136.3 52.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 -171.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.8 m -110.75 122.72 48.52 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -75.55 152.39 37.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.429 0.633 . . . . 0.0 112.035 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.441 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 64.2 tttp -137.79 131.32 16.95 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.436 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.9 Cg_endo -60.53 124.91 16.04 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.117 1.878 . . . . 0.0 111.203 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -51.91 133.45 32.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' B' ' 29' ' ' GLU . . . -102.17 3.78 51.61 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -115.13 -20.45 10.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -90.63 167.06 12.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.012 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -158.25 151.02 22.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.737 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.83 -149.64 45.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.939 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.18 139.65 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 120.815 0.341 . . . . 0.0 110.603 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.0 t -104.28 148.32 26.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.144 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.62 32.25 1.22 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.576 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.8 p30 -165.06 129.79 2.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -89.25 -30.8 18.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.706 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.84 -49.8 5.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.219 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -61.27 -47.93 83.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.269 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.588 ' O ' HG12 ' B' ' 26' ' ' ILE . 55.5 ttp180 -60.75 -51.32 69.85 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.121 0.486 . . . . 0.0 109.746 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -55.08 -48.69 73.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.176 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.408 ' CG ' HD12 ' B' ' 28' ' ' LEU . 17.0 tt0 -60.51 -45.04 95.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 98.8 m -56.17 -42.76 77.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.588 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.8 mm -54.88 -56.72 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.746 0.784 . . . . 0.0 111.004 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.88 -63.6 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.828 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CG ' ' B' ' 24' ' ' GLN . 83.0 mt -72.18 -35.75 69.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.684 -170.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' B' ' 9' ' ' GLY . 35.2 mt-10 -108.46 3.4 23.15 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.929 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp 58.67 34.32 23.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.041 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -86.77 154.61 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.333 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -90.1 -22.38 21.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.24 166.27 33.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.02 161.73 31.72 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -152.62 144.77 23.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.807 0.304 . . . . 0.0 110.666 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 35.8 t -90.43 79.94 6.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' ND2' HG13 ' B' ' 46' ' ' ILE . 23.1 p-10 -71.07 167.78 18.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.316 -171.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -110.62 77.37 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.075 0.464 . . . . 0.0 110.273 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.52 102.1 6.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 55.9 t80 -43.22 137.2 2.85 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.173 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 44.1 Cg_endo -99.86 24.54 18.7 Favored 'Cis proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.155 -1.185 . . . . 0.0 114.694 3.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.92 163.4 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 112.241 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 54.9 m-70 -86.24 128.12 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.303 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -118.01 168.88 10.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.166 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.02 116.08 28.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.678 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 45.8 mm -115.98 117.15 54.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.534 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.01 145.48 27.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' B' ' 3' ' ' LEU . 3.5 m-85 -110.02 122.53 47.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.923 0.392 . . . . 0.0 110.766 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.0 m-85 -116.5 139.19 25.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.874 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HA ' HD23 ' B' ' 3' ' ' LEU . 53.4 Cg_exo -53.14 115.68 2.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.811 2.341 . . . . 0.0 111.656 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.263 -174.308 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.094 0.474 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -90.2 -178.1 5.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 0.0 111.76 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 50' ' ' PRO . 52.0 mt -108.75 145.67 34.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.915 -175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 99.0 m -109.17 129.0 55.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.597 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.0 OUTLIER -84.19 147.91 27.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.491 0.662 . . . . 0.0 112.019 -170.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -136.29 126.4 16.25 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.679 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.565 ' HA ' HD13 ' B' ' 46' ' ' ILE . 26.9 Cg_exo -60.45 133.68 50.44 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.069 1.846 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 79.2 p -53.08 127.77 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.565 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.89 4.07 56.01 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.4 p -120.17 -0.88 10.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.48 0.657 . . . . 0.0 110.334 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' TRP . . . . . 0.46 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 6.3 t-105 -126.21 169.83 12.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -160.66 133.31 6.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.24 -165.67 34.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.942 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.99 120.32 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.057 0.456 . . . . 0.0 110.003 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 3.3 p -88.85 135.65 33.42 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.95 38.57 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.815 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 41.6 m-80 -122.01 120.89 35.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.805 0.336 . . . . 0.0 110.553 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -66.67 -31.18 71.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.693 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.74 -36.45 37.18 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.49 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.79 -38.51 91.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -59.93 -47.25 86.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.72 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.671 ' O ' HG12 ' B' ' 26' ' ' ILE . 38.9 ttt180 -58.95 -52.13 67.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -58.42 -36.51 73.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.321 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.29 -43.8 73.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 72.7 m -58.73 -40.19 83.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.596 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.671 HG12 ' O ' ' B' ' 22' ' ' ARG . 26.8 mm -54.61 -60.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.71 0.767 . . . . 0.0 110.756 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -69.02 -61.9 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.757 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -79.95 -43.24 22.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.223 -168.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.57 1.2 40.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.939 -172.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 58.9 36.0 24.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.968 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -88.35 151.12 22.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -83.73 -33.43 25.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' HIS . . . . . 0.534 ' CE1' ' HD2' ' B' ' 22' ' ' ARG . 73.5 t60 -139.66 166.48 24.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -161.95 156.4 27.94 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -170.14 154.03 4.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.199 0.499 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' B' ' 44' ' ' LYS . 84.1 m -84.89 81.44 8.89 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.521 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -61.97 160.64 11.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.675 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -98.56 85.24 3.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 111.497 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.78 104.61 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.7 t80 -46.65 135.55 7.78 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.365 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.9 Cg_endo -99.59 21.37 22.27 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.962 -1.266 . . . . 0.0 113.417 0.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.5 -175.51 3.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.275 0.559 . . . . 0.0 111.834 -172.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -114.98 133.41 56.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.092 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 36' ' ' CYS . 40.0 mmtm -123.53 148.98 45.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.287 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.62 120.54 20.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.209 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.597 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 32.6 mm -127.11 119.72 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 25.4 m -86.68 142.57 28.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.487 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 85.0 m-85 -110.58 122.57 48.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.042 0.448 . . . . 0.0 111.048 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 90.7 m-85 -113.91 135.31 22.04 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.484 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 38.4 Cg_exo -59.4 125.04 16.84 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.042 2.495 . . . . 0.0 113.072 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.298 -0.858 . . . . 0.0 109.953 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.838 0.351 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -121.46 -168.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.183 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt -54.05 152.18 6.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.8 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -93.03 120.35 33.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.954 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 7.9 mp0 -81.98 136.48 35.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.946 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -131.01 123.85 20.19 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.408 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.6 Cg_endo -53.55 125.99 20.33 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.544 2.163 . . . . 0.0 111.909 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -55.82 143.66 30.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.285 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.91 10.87 20.79 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.189 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -118.44 -19.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' B' ' 15' ' ' CYS . 7.3 t-105 -98.66 171.77 7.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.987 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.0 p -157.17 129.02 7.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 -148.27 39.49 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.674 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 142.31 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 120.919 0.39 . . . . 0.0 110.347 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.484 ' HA ' ' NE1' ' B' ' 11' ' ' TRP . 15.6 p -96.03 170.68 9.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.03 -62.79 2.28 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.592 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -154.22 167.19 30.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -54.37 -50.47 67.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.41 0.444 . . . . 0.0 111.852 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.32 -36.22 78.09 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.243 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.26 78.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.155 0.503 . . . . 0.0 109.795 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' B' ' 36' ' ' CYS . 25.3 t -69.18 -46.65 66.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.825 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 42.9 ttp180 -56.64 -54.4 46.47 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.953 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -61.98 -48.71 79.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.159 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -54.9 -41.09 70.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.027 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 18.5 mm -56.09 -60.15 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.772 0.796 . . . . 0.0 110.475 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 27' ' ' ARG . 42.0 mtm180 -72.95 -56.17 5.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.88 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.64 -32.56 31.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.795 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -112.47 6.48 18.59 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.609 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 55.35 35.23 24.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.431 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -84.21 153.47 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.852 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -88.03 -28.2 21.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 0.0 110.778 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -148.81 171.12 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.49 156.75 26.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.6 m -161.56 134.85 6.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' B' ' 21' ' ' CYS . 97.4 m -67.04 139.0 57.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.958 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' B' ' 43' ' ' HIS . 36.0 p-10 -117.6 169.86 9.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.202 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.79 64.32 0.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.244 0.545 . . . . 0.0 110.248 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.76 92.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 167.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 81.5 t80 -46.47 138.15 6.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.851 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.3 Cg_endo -100.26 29.62 12.59 Favored 'Cis proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.143 -1.191 . . . . 0.0 114.758 4.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.73 151.02 46.77 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.418 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 9.2 m-70 -89.96 91.99 8.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.875 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.33 174.02 11.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.005 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 45.4 t -100.1 116.47 32.2 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.079 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.662 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 35.4 mm -116.08 116.51 52.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.056 0.455 . . . . 0.0 110.427 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 m -83.38 149.83 26.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.054 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.29 125.07 53.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.058 0.456 . . . . 0.0 111.032 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.56 139.69 28.24 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.545 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.19 124.82 17.19 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.807 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.127 178.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' B' ' 50' ' ' PRO . 19.9 mt . . . . . 0 C--O 1.232 0.151 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.458 ' H ' ' HB2' ' B' ' 51' ' ' CYS . 7.3 m -89.44 113.41 24.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.568 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -75.55 153.26 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.982 -173.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -141.48 126.22 10.54 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.526 ' HA ' HD13 ' B' ' 46' ' ' ILE . 18.9 Cg_endo -59.21 124.34 15.39 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.065 1.843 . . . . 0.0 111.53 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' B' ' 45' ' ' CYS . 67.8 m -51.49 112.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.834 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 -0.3 78.23 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -105.88 -6.48 18.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.964 0.887 . . . . 0.0 109.228 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -104.13 168.41 9.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.843 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -159.98 147.06 16.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.28 -151.88 47.47 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.591 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.33 156.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.79 140.5 52.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.236 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.7 26.68 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.237 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 7.1 p30 -164.05 147.25 9.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.886 0.343 . . . . 0.0 110.539 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -103.18 -31.83 9.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.34 -52.3 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.44 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -59.04 -38.2 78.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -49.69 76.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.95 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.6 ttp180 -60.08 -53.1 61.72 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 12.7 t30 -53.26 -46.11 69.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.882 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.24 -48.92 79.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.412 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.593 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.9 m -55.89 -40.93 73.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.979 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 22.1 mm -56.08 -61.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.154 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 10.3 ptm180 -80.58 -42.66 21.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.249 -170.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 44.0 mt -86.52 -43.6 12.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.627 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -102.29 2.49 37.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.06 27.1 16.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.977 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -82.51 151.03 26.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.381 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -85.23 -29.82 24.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.011 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 86.5 t60 -142.66 160.73 39.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.56 155.35 26.55 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -160.8 170.81 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.094 0.473 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 19.4 t -103.35 75.78 1.37 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.434 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.558 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.91 153.23 43.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.789 -172.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -100.63 85.47 2.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 39' ' ' VAL . 1.8 m -82.75 98.03 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 74.5 t80 -44.51 134.29 4.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.433 -174.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 29.3 Cg_endo -100.44 30.17 11.82 Favored 'Cis proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.797 -1.335 . . . . 0.0 114.252 2.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.62 151.82 48.72 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . 0.518 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 32.5 m-70 -84.0 124.39 31.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.985 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -125.36 147.77 49.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.207 0.527 . . . . 0.0 110.355 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' B' ' 8' ' ' SER . 6.1 t -79.22 124.17 28.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 38.9 mm -128.06 119.31 50.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.671 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -88.44 145.65 25.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 82.8 m-85 -110.68 128.3 55.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.85 0.357 . . . . 0.0 111.007 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 138.44 27.05 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.937 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' B' ' 3' ' ' LEU . 62.0 Cg_exo -53.56 116.39 2.95 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 C-N-CA 123.133 2.556 . . . . 0.0 111.947 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' B' ' 4' ' ' CYS . 5.9 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.485 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 48' ' ' TYR . 26.9 mt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 m -104.21 126.76 51.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.717 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 0.7 OUTLIER -78.78 140.06 38.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.324 0.583 . . . . 0.0 111.302 -175.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 5' ' ' GLU . 14.2 mptt -133.68 128.47 19.96 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.192 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.48 129.37 26.4 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.82 1.68 . . . . 0.0 110.984 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -55.98 130.64 44.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.304 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.15 9.03 59.41 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.216 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.8 p -116.34 -25.73 7.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.281 0.562 . . . . 0.0 109.932 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -79.6 170.4 16.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.208 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -148.29 131.61 16.55 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.666 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.4 -141.7 32.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.031 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.43 145.52 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.12 144.81 35.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.37 -21.11 3.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.073 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.409 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 32.9 m-80 -123.79 125.0 43.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.426 0.155 . . . . 0.0 111.213 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.9 p-10 -77.71 -37.9 48.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 0.0 111.17 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.48 -38.32 21.44 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.57 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -63.78 -34.78 78.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 20.7 t -66.14 -47.9 72.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.926 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.645 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.1 ttp180 -54.75 -52.59 62.07 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -55.29 -47.57 75.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.054 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -62.46 -47.15 85.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.224 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 96.5 m -54.9 -39.72 69.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.952 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.645 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.7 mm -58.34 -65.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.514 0.674 . . . . 0.0 110.989 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.446 ' HG3' ' HG ' ' B' ' 28' ' ' LEU . 17.3 ptp180 -71.94 -43.26 65.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.083 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' B' ' 27' ' ' ARG . 69.1 mt -88.16 -42.68 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -172.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.21 -0.1 28.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' B' ' 30' ' ' LYS . 7.1 mtmp? 66.29 25.46 10.48 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.322 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -77.32 152.09 34.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.928 0.394 . . . . 0.0 110.85 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 32.6 mmm180 -82.45 -33.42 28.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.494 0.664 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -147.68 160.47 42.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -152.44 151.33 23.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.3 t -150.31 152.57 34.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.037 0.419 . . . . 0.0 110.087 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 18' ' ' ASN . 15.6 t -91.45 66.19 5.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.754 0.788 . . . . 0.0 109.09 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.448 HD22 HG13 ' B' ' 46' ' ' ILE . 0.1 OUTLIER -74.92 157.02 35.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.464 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.23 89.07 7.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.467 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.67 96.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 168.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -40.12 135.61 1.37 Allowed Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 123.823 0.702 . . . . 0.0 111.361 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -100.15 28.47 14.05 Favored 'Cis proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.956 -1.268 . . . . 0.0 114.065 3.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.42 33.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.0 111.956 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -77.27 127.2 32.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.908 173.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -123.08 145.84 48.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 42.6 t -73.75 106.51 5.52 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.913 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.717 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 31.1 mm -110.39 110.16 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.155 0.502 . . . . 0.0 110.653 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 46.0 m -79.06 148.51 32.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.407 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' B' ' 3' ' ' LEU . 74.4 m-85 -112.7 123.85 51.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.088 0.47 . . . . 0.0 111.437 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.452 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 95.6 m-85 -121.41 134.83 24.62 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.123 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 51.4 Cg_exo -51.5 125.16 15.94 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.85 2.367 . . . . 0.0 112.58 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.77 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.6 114.15 19.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.156 0.503 . . . . 0.0 109.753 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.649 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -68.38 153.07 44.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.262 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -142.47 125.94 9.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.163 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.496 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.5 Cg_endo -59.53 122.11 10.97 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.347 2.032 . . . . 0.0 111.742 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.4 p -49.49 128.97 18.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.483 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.92 5.67 42.93 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -114.39 -11.63 12.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.57 0.7 . . . . 0.0 110.257 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -92.41 171.1 9.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.876 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.8 m -154.49 139.25 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.602 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.51 -155.33 48.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.381 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.99 156.22 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 120.94 0.4 . . . . 0.0 110.075 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.22 147.35 40.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.446 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.71 22.76 2.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.821 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.2 p30 -158.17 137.19 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -88.6 -29.61 19.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.048 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.42 -56.68 2.77 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.683 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -58.55 -36.49 73.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.001 0.429 . . . . 0.0 109.928 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -61.44 -49.05 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.621 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.592 ' O ' HG12 ' B' ' 26' ' ' ILE . 35.9 ttm180 -63.44 -50.4 69.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 109.742 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -56.89 -43.18 81.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -58.7 -51.22 70.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.375 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 99.4 m -53.73 -40.58 66.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.186 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' B' ' 31' ' ' ALA . 19.0 mm -56.68 -58.33 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 121.375 0.607 . . . . 0.0 111.196 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' B' ' 27' ' ' ARG . 13.4 ptp180 -79.06 -45.84 19.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.925 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.88 -60.26 2.45 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.602 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.91 3.55 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 111.969 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 60.28 31.16 20.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -81.93 148.71 28.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.498 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -85.6 -25.61 26.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . 0.563 ' CE1' ' HD3' ' B' ' 22' ' ' ARG . 36.2 t60 -152.44 177.29 10.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.41 175.8 47.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.585 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 4.8 t -173.6 156.7 3.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 17.2 t -89.77 73.18 7.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.465 0.65 . . . . 0.0 109.258 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.602 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -65.44 151.79 45.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.186 -172.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -92.08 81.47 5.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.353 0.597 . . . . 0.0 110.406 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.55 99.23 5.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 34.9 t80 -44.0 132.86 4.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.452 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 52.9 Cg_endo -101.21 23.36 17.43 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.13 -1.196 . . . . 0.0 114.205 2.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.12 41.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -90.58 125.33 35.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.865 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.52 151.74 50.67 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.094 0.473 . . . . 0.0 110.623 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -76.43 120.49 21.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.649 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 44.5 mm -123.24 116.67 49.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 35.9 m -86.02 136.86 33.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.879 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -101.12 123.33 45.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.863 0.363 . . . . 0.0 110.477 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 94.4 m-85 -116.27 138.46 24.29 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.686 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 13.4 Cg_exo -68.0 116.12 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.463 2.109 . . . . 0.0 111.781 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.364 177.312 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 50' ' ' PRO . 64.8 mt . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 120.741 0.305 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -112.98 118.06 33.77 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.617 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -67.7 152.36 45.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.848 -173.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -142.55 131.73 11.93 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.13 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.55 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.0 Cg_endo -58.16 129.58 33.69 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.245 1.964 . . . . 0.0 111.697 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 39.7 t -58.09 132.53 53.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 0.0 110.974 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.3 11.89 47.8 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -117.64 -20.66 8.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.573 0.702 . . . . 0.0 109.727 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -87.73 170.52 11.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.351 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.3 m -140.97 121.1 13.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.68 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.33 -152.03 51.54 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.746 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.72 148.4 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 8.0 p -110.62 146.88 35.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.762 0.315 . . . . 0.0 111.176 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.37 -7.36 34.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.332 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 42.8 m-80 -139.14 108.66 6.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.449 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -73.53 -31.47 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.744 0.307 . . . . 0.0 110.979 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.7 -38.87 22.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.337 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -62.09 -38.74 90.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.97 -49.29 78.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.652 ' O ' HG12 ' B' ' 26' ' ' ILE . 43.5 ttp180 -54.31 -55.95 23.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' B' ' 27' ' ' ARG . 40.8 t30 -53.62 -46.99 70.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.551 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -60.65 -48.21 82.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.398 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.1 m -54.69 -40.7 69.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.032 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.652 HG12 ' O ' ' B' ' 22' ' ' ARG . 14.7 mm -58.92 -58.76 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.762 0.791 . . . . 0.0 110.303 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 23' ' ' ASN . 70.7 mtp180 -71.29 -51.81 22.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.281 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.01 -26.88 18.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -115.36 4.95 14.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.972 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.13 29.19 18.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.594 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -83.82 157.57 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.992 0.425 . . . . 0.0 110.475 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -90.0 -26.65 20.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.827 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -153.49 168.56 25.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.11 160.94 34.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -176.1 160.14 2.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 43' ' ' HIS . 69.8 m -85.29 91.35 8.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' CG1' ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.25 165.12 21.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -96.32 93.05 6.64 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.332 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -95.87 107.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.1 t80 -45.02 135.49 4.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.864 0.728 . . . . 0.0 111.572 -173.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.4 Cg_endo -100.07 21.61 21.01 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.807 -1.33 . . . . 0.0 113.508 1.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.9 178.81 6.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.353 0.596 . . . . 0.0 112.148 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 36' ' ' CYS . 55.0 m-70 -100.27 119.03 37.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.087 175.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -107.81 145.13 34.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -72.53 115.2 11.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.52 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.617 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 37.8 mm -124.89 128.17 73.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 -174.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.7 m -96.86 151.75 19.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.702 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -111.48 125.44 53.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.4 142.14 31.99 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.201 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' B' ' 3' ' ' LEU . 76.3 Cg_exo -53.15 118.2 4.57 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.04 2.493 . . . . 0.0 112.392 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.691 -178.347 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 50' ' ' PRO . 48.6 mt . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.701 0.286 . . . . 0.0 111.606 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 m -98.17 123.93 42.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.638 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -74.71 150.25 39.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.769 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.443 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 49.6 tttm -133.93 134.28 23.02 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.431 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.455 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.8 Cg_endo -62.03 130.66 31.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.672 1.581 . . . . 0.0 110.619 173.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -58.72 134.06 56.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.05 16.34 42.78 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -125.98 -26.57 3.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.056 0.455 . . . . 0.0 110.784 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -87.33 170.89 11.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.585 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -148.28 124.03 10.54 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.31 -162.81 54.31 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.78 144.12 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -92.53 167.54 11.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.801 0.334 . . . . 0.0 110.225 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.35 -11.25 10.81 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.891 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 43.5 m-80 -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.46 -41.43 76.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.26 58.91 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.594 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.41 -38.73 92.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.74 -46.85 80.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.111 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.631 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.0 ttp180 -60.94 -52.41 65.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.839 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 40.0 t30 -53.48 -46.18 69.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.519 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -59.16 -48.45 81.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 82.3 m -54.64 -43.24 72.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.643 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.631 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.5 mm -55.93 -55.54 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.399 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 23.2 mmt180 -74.74 -63.72 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.565 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.23 -48.79 26.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.836 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.68 -0.2 57.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 59.69 38.59 21.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.06 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -88.69 150.82 22.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -83.54 -25.32 31.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -153.14 167.3 29.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.353 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.3 162.34 35.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 88.0 p -159.6 145.16 15.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.829 0.315 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 6.8 t -82.33 76.18 9.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.464 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -67.43 152.46 45.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.298 -172.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -90.56 77.08 6.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.685 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.27 101.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 56.2 t80 -43.31 135.13 3.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.393 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 42.3 Cg_endo -101.22 25.94 15.45 Favored 'Cis proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.575 4.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 163.83 31.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . 0.452 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 42.8 m-70 -89.75 117.71 28.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.55 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -119.51 154.83 33.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.14 0.495 . . . . 0.0 110.53 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.36 110.48 10.92 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.249 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 43.2 mm -118.84 116.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 m -86.89 153.37 21.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.12 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.37 130.52 56.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.956 0.408 . . . . 0.0 111.066 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.1 m-85 -126.42 142.19 42.23 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.167 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.437 ' HA ' HD23 ' B' ' 3' ' ' LEU . 77.3 Cg_exo -52.16 118.97 5.08 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.803 2.335 . . . . 0.0 111.827 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.44 -177.253 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.038 0.446 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 72.1 m -117.05 116.85 28.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.461 0.648 . . . . 0.0 110.583 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.658 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.5 mp0 -74.72 149.51 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.902 -171.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.69 125.55 11.94 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.538 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.459 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.8 Cg_endo -53.71 125.45 18.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.626 2.218 . . . . 0.0 112.477 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -59.15 139.48 56.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.86 13.56 26.93 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -119.93 8.59 11.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.578 0.704 . . . . 0.0 109.898 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -124.45 172.25 9.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.538 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -167.56 158.03 11.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 -164.31 54.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.321 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -83.85 128.74 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 t -81.3 133.28 35.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -29.25 4.12 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.914 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -126.84 114.94 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 111.26 -168.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.3 p-10 -72.94 -32.8 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.95 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.52 -52.05 23.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.579 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.32 -37.67 72.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.9 t -61.5 -47.5 85.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.51 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.66 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.9 ttp85 -62.04 -49.51 75.7 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -59.33 -43.77 92.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.549 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' B' ' 24' ' ' GLN . 1.7 mt-30 -58.19 -45.75 86.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.771 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 87.2 m -60.23 -41.13 92.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.824 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.66 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.9 mm -58.33 -58.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.464 0.65 . . . . 0.0 110.642 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -73.79 -61.37 1.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.666 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 mt -74.46 -40.43 61.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.988 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -107.87 5.27 26.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.989 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt 56.75 32.86 21.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.965 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -80.99 149.56 29.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.627 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -77.85 -30.94 51.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.071 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -151.8 167.6 27.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.952 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.408 ' N ' ' HG3' ' B' ' 22' ' ' ARG . . . -161.33 165.05 35.3 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -160.58 155.44 24.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.974 0.387 . . . . 0.0 110.121 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 26.2 t -91.44 72.23 6.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -62.58 153.6 31.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.598 -172.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -96.54 79.55 3.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.857 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.2 101.25 4.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -46.35 134.73 7.42 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.703 -171.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -102.08 28.04 12.24 Favored 'Cis proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.049 -1.23 . . . . 0.0 113.849 2.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.0 170.81 15.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 112.13 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . 0.636 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 51.4 m-70 -100.01 130.16 46.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -127.65 148.47 50.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.267 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 35.4 t -74.21 117.33 15.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.658 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 36.1 mm -126.63 119.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.455 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 37.5 m -84.21 151.23 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.33 121.78 45.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.086 0.469 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.37 135.32 24.92 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.236 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.88 117.85 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.283 1.989 . . . . 0.0 112.178 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' B' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.318 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.113 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.097 0.475 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 36.4 m -120.38 125.74 48.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.02 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.67 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.9 mp0 -76.89 139.09 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.401 0.62 . . . . 0.0 111.483 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' HD2' ' B' ' 49' ' ' PHE . 2.1 mptm? -132.46 141.46 41.33 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.211 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.33 138.46 60.78 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.06 1.84 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.9 p -59.76 131.79 51.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.371 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.08 14.61 33.79 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.488 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.8 p -131.85 -9.42 3.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . 0.517 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 19.4 t-105 -104.86 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.321 0.582 . . . . 0.0 110.376 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' B' ' 11' ' ' TRP . 26.9 m -89.7 -155.97 0.39 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.768 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.61 -116.14 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.242 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.57 147.74 6.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.487 . . . . 0.0 111.347 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 6.5 p -130.64 147.93 52.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.227 0.537 . . . . 0.0 110.929 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.64 -45.48 6.41 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.246 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 40.9 m-80 -116.51 126.98 54.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.765 0.317 . . . . 0.0 110.792 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -70.38 -28.08 64.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.65 -34.42 25.15 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.751 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -64.98 -38.58 91.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -61.5 -49.24 77.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.792 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.634 ' O ' HG12 ' B' ' 26' ' ' ILE . 50.1 ttp180 -52.5 -55.3 22.96 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.155 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -51.96 -48.58 64.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.903 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -64.0 -44.71 91.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 74.6 m -55.56 -41.12 72.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.453 174.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.634 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.1 mm -56.97 -59.14 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.47 0.653 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -80.69 -51.02 9.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.345 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -79.36 -42.92 24.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.75 1.46 37.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' B' ' 26' ' ' ILE . 34.7 mmtp 57.81 29.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.885 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -78.26 151.35 33.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.985 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' B' ' 32' ' ' ARG . 4.3 mmp_? -83.11 -24.93 32.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -153.56 167.01 30.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.482 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.34 158.64 31.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.3 m -162.18 151.99 16.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.074 0.437 . . . . 0.0 110.539 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -76.38 81.83 3.12 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.203 0.525 . . . . 0.0 109.986 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.42 HD22 HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -78.17 156.98 29.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -175.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.98 83.2 7.85 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.835 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 95.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 167.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 82.7 t80 -44.26 135.04 4.26 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.628 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 31.8 Cg_endo -100.03 29.92 12.44 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.874 -1.302 . . . . 0.0 113.807 1.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.33 167.49 21.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.324 0.583 . . . . 0.0 112.052 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.37 111.07 22.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.827 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -105.75 147.39 28.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.722 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.5 t -73.6 114.98 12.47 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 30.1 mm -121.13 118.52 56.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.112 0.482 . . . . 0.0 110.887 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.6 m -84.78 148.3 26.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.817 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.01 121.5 45.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.922 0.391 . . . . 0.0 110.916 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 98.0 m-85 -117.87 138.56 25.47 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.341 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.85 123.15 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.645 2.23 . . . . 0.0 111.982 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.859 178.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 50' ' ' PRO . 67.0 mt . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.8 m -110.75 122.72 48.52 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -75.55 152.39 37.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.429 0.633 . . . . 0.0 112.035 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.441 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 64.2 tttp -137.79 131.32 16.95 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.436 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.9 Cg_endo -60.53 124.91 16.04 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.117 1.878 . . . . 0.0 111.203 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -51.91 133.45 32.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' B' ' 29' ' ' GLU . . . -102.17 3.78 51.61 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -115.13 -20.45 10.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -90.63 167.06 12.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.012 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -158.25 151.02 22.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.737 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.83 -149.64 45.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.939 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.18 139.65 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 120.815 0.341 . . . . 0.0 110.603 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.0 t -104.28 148.32 26.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.144 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.62 32.25 1.22 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.576 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.8 p30 -165.06 129.79 2.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -89.25 -30.8 18.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.706 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.84 -49.8 5.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.219 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -61.27 -47.93 83.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.269 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.588 ' O ' HG12 ' B' ' 26' ' ' ILE . 55.5 ttp180 -60.75 -51.32 69.85 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.121 0.486 . . . . 0.0 109.746 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -55.08 -48.69 73.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.176 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.408 ' CG ' HD12 ' B' ' 28' ' ' LEU . 17.0 tt0 -60.51 -45.04 95.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 98.8 m -56.17 -42.76 77.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.588 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.8 mm -54.88 -56.72 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.746 0.784 . . . . 0.0 111.004 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.88 -63.6 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.828 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CG ' ' B' ' 24' ' ' GLN . 83.0 mt -72.18 -35.75 69.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.684 -170.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' B' ' 9' ' ' GLY . 35.2 mt-10 -108.46 3.4 23.15 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.929 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp 58.67 34.32 23.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.041 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -86.77 154.61 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.333 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -90.1 -22.38 21.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.24 166.27 33.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.02 161.73 31.72 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -152.62 144.77 23.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.807 0.304 . . . . 0.0 110.666 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 35.8 t -90.43 79.94 6.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.465 ' ND2' HG13 ' B' ' 46' ' ' ILE . 23.1 p-10 -71.07 167.78 18.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.316 -171.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -110.62 77.37 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.075 0.464 . . . . 0.0 110.273 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.52 102.1 6.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 55.9 t80 -43.22 137.2 2.85 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.173 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 44.1 Cg_endo -99.86 24.54 18.7 Favored 'Cis proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.155 -1.185 . . . . 0.0 114.694 3.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.92 163.4 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 112.241 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 54.9 m-70 -86.24 128.12 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.303 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -118.01 168.88 10.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.166 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.02 116.08 28.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.678 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 45.8 mm -115.98 117.15 54.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.534 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.01 145.48 27.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' B' ' 3' ' ' LEU . 3.5 m-85 -110.02 122.53 47.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.923 0.392 . . . . 0.0 110.766 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.0 m-85 -116.5 139.19 25.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.874 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HA ' HD23 ' B' ' 3' ' ' LEU . 53.4 Cg_exo -53.14 115.68 2.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.811 2.341 . . . . 0.0 111.656 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.263 -174.308 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 50' ' ' PRO . 52.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 99.0 m -109.17 129.0 55.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.597 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.0 OUTLIER -84.19 147.91 27.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.491 0.662 . . . . 0.0 112.019 -170.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -136.29 126.4 16.25 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.679 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.565 ' HA ' HD13 ' B' ' 46' ' ' ILE . 26.9 Cg_exo -60.45 133.68 50.44 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.069 1.846 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 79.2 p -53.08 127.77 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.565 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.89 4.07 56.01 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.4 p -120.17 -0.88 10.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.48 0.657 . . . . 0.0 110.334 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . 0.46 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 6.3 t-105 -126.21 169.83 12.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -160.66 133.31 6.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.24 -165.67 34.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.942 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.99 120.32 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.057 0.456 . . . . 0.0 110.003 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 3.3 p -88.85 135.65 33.42 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.95 38.57 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.815 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 41.6 m-80 -122.01 120.89 35.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.805 0.336 . . . . 0.0 110.553 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -66.67 -31.18 71.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.693 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.74 -36.45 37.18 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.49 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.79 -38.51 91.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -59.93 -47.25 86.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.72 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.671 ' O ' HG12 ' B' ' 26' ' ' ILE . 38.9 ttt180 -58.95 -52.13 67.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -58.42 -36.51 73.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.321 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.411 ' NE2' ' HE3' ' B' ' 11' ' ' TRP . 0.0 OUTLIER -69.29 -43.8 73.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 72.7 m -58.73 -40.19 83.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.596 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.671 HG12 ' O ' ' B' ' 22' ' ' ARG . 26.8 mm -54.61 -60.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.71 0.767 . . . . 0.0 110.756 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -69.02 -61.9 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.757 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -79.95 -43.24 22.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.223 -168.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.57 1.2 40.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.939 -172.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 58.9 36.0 24.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.968 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -88.35 151.12 22.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -83.73 -33.43 25.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . 0.534 ' CE1' ' HD2' ' B' ' 22' ' ' ARG . 73.5 t60 -139.66 166.48 24.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -161.95 156.4 27.94 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -170.14 154.03 4.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.199 0.499 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' B' ' 44' ' ' LYS . 84.1 m -84.89 81.44 8.89 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.521 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 160.64 11.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.675 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -98.56 85.24 3.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 111.497 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.78 104.61 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.7 t80 -46.65 135.55 7.78 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.365 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.9 Cg_endo -99.59 21.37 22.27 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.962 -1.266 . . . . 0.0 113.417 0.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.5 -175.51 3.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.275 0.559 . . . . 0.0 111.834 -172.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -114.98 133.41 56.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.092 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 36' ' ' CYS . 40.0 mmtm -123.53 148.98 45.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.287 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.62 120.54 20.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.209 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.597 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 32.6 mm -127.11 119.72 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 25.4 m -86.68 142.57 28.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.487 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 85.0 m-85 -110.58 122.57 48.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.042 0.448 . . . . 0.0 111.048 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 90.7 m-85 -113.91 135.31 22.04 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.484 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 38.4 Cg_exo -59.4 125.04 16.84 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.042 2.495 . . . . 0.0 113.072 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.298 -0.858 . . . . 0.0 109.953 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -93.03 120.35 33.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.954 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 7.9 mp0 -81.98 136.48 35.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.946 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -131.01 123.85 20.19 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.408 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.6 Cg_endo -53.55 125.99 20.33 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.544 2.163 . . . . 0.0 111.909 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -55.82 143.66 30.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.285 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.91 10.87 20.79 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.189 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -118.44 -19.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' B' ' 15' ' ' CYS . 7.3 t-105 -98.66 171.77 7.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.987 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.0 p -157.17 129.02 7.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 -148.27 39.49 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.674 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 142.31 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 120.919 0.39 . . . . 0.0 110.347 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.484 ' HA ' ' NE1' ' B' ' 11' ' ' TRP . 15.6 p -96.03 170.68 9.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.03 -62.79 2.28 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.592 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -154.22 167.19 30.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -54.37 -50.47 67.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.41 0.444 . . . . 0.0 111.852 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.32 -36.22 78.09 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.243 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.26 78.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.155 0.503 . . . . 0.0 109.795 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' B' ' 36' ' ' CYS . 25.3 t -69.18 -46.65 66.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.825 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 42.9 ttp180 -56.64 -54.4 46.47 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.953 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -61.98 -48.71 79.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.159 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -54.9 -41.09 70.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.027 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 18.5 mm -56.09 -60.15 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.772 0.796 . . . . 0.0 110.475 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 27' ' ' ARG . 42.0 mtm180 -72.95 -56.17 5.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.88 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.64 -32.56 31.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.795 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -112.47 6.48 18.59 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.609 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 55.35 35.23 24.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.431 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -84.21 153.47 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.852 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -88.03 -28.2 21.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 0.0 110.778 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -148.81 171.12 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.49 156.75 26.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.6 m -161.56 134.85 6.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' B' ' 21' ' ' CYS . 97.4 m -67.04 139.0 57.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.958 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' B' ' 43' ' ' HIS . 36.0 p-10 -117.6 169.86 9.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.202 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.79 64.32 0.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.244 0.545 . . . . 0.0 110.248 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.76 92.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 167.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 81.5 t80 -46.47 138.15 6.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.851 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.3 Cg_endo -100.26 29.62 12.59 Favored 'Cis proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.143 -1.191 . . . . 0.0 114.758 4.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.73 151.02 46.77 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.418 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 9.2 m-70 -89.96 91.99 8.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.875 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.33 174.02 11.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.005 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 45.4 t -100.1 116.47 32.2 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.079 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.662 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 35.4 mm -116.08 116.51 52.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.056 0.455 . . . . 0.0 110.427 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 m -83.38 149.83 26.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.054 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.29 125.07 53.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.058 0.456 . . . . 0.0 111.032 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.56 139.69 28.24 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.545 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.19 124.82 17.19 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.807 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.127 178.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.413 0.149 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -74.86 -168.41 0.73 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.389 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' B' ' 50' ' ' PRO . 19.9 mt -52.37 134.64 34.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.293 172.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.458 ' H ' ' HB2' ' B' ' 51' ' ' CYS . 7.3 m -89.44 113.41 24.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.568 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -75.55 153.26 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.982 -173.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -141.48 126.22 10.54 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.526 ' HA ' HD13 ' B' ' 46' ' ' ILE . 18.9 Cg_endo -59.21 124.34 15.39 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.065 1.843 . . . . 0.0 111.53 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' B' ' 45' ' ' CYS . 67.8 m -51.49 112.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.834 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.92 -0.3 78.23 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 21.3 p -105.88 -6.48 18.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.964 0.887 . . . . 0.0 109.228 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -104.13 168.41 9.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.843 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.0 m -159.98 147.06 16.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.28 -151.88 47.47 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.591 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.33 156.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.79 140.5 52.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.236 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.7 26.68 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.237 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 7.1 p30 -164.05 147.25 9.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.886 0.343 . . . . 0.0 110.539 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -103.18 -31.83 9.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.34 -52.3 5.26 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.44 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -59.04 -38.2 78.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.32 -49.69 76.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.95 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.6 ttp180 -60.08 -53.1 61.72 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 12.7 t30 -53.26 -46.11 69.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.882 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.24 -48.92 79.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.412 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.593 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.9 m -55.89 -40.93 73.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.979 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 22.1 mm -56.08 -61.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.154 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 10.3 ptm180 -80.58 -42.66 21.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.249 -170.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 44.0 mt -86.52 -43.6 12.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.627 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -102.29 2.49 37.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.917 0.389 . . . . 0.0 111.363 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 61.06 27.1 16.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.977 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -82.51 151.03 26.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.381 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -85.23 -29.82 24.35 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.011 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . 0.403 ' HB3' ' HB2' ' B' ' 48' ' ' TYR . 86.5 t60 -142.66 160.73 39.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.56 155.35 26.55 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -160.8 170.81 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.094 0.473 . . . . 0.0 110.789 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 19.4 t -103.35 75.78 1.37 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.434 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.558 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.91 153.23 43.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.789 -172.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -100.63 85.47 2.93 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.17 0.509 . . . . 0.0 111.272 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 39' ' ' VAL . 1.8 m -82.75 98.03 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 74.5 t80 -44.51 134.29 4.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.433 -174.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 29.3 Cg_endo -100.44 30.17 11.82 Favored 'Cis proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.797 -1.335 . . . . 0.0 114.252 2.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.62 151.82 48.72 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . 0.518 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 32.5 m-70 -84.0 124.39 31.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.985 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -125.36 147.77 49.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.207 0.527 . . . . 0.0 110.355 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' B' ' 8' ' ' SER . 6.1 t -79.22 124.17 28.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.214 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 38.9 mm -128.06 119.31 50.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.671 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -88.44 145.65 25.65 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 82.8 m-85 -110.68 128.3 55.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.85 0.357 . . . . 0.0 111.007 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 138.44 27.05 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.937 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' B' ' 3' ' ' LEU . 62.0 Cg_exo -53.56 116.39 2.95 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 C-N-CA 123.133 2.556 . . . . 0.0 111.947 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' B' ' 4' ' ' CYS . 5.9 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.485 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.03 0.443 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -89.03 -163.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.501 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.404 ' HB3' ' HB3' ' B' ' 48' ' ' TYR . 26.9 mt -68.14 154.64 41.28 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.16 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 m -104.21 126.76 51.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.717 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 0.7 OUTLIER -78.78 140.06 38.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.324 0.583 . . . . 0.0 111.302 -175.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 5' ' ' GLU . 14.2 mptt -133.68 128.47 19.96 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.192 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.48 129.37 26.4 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.82 1.68 . . . . 0.0 110.984 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -55.98 130.64 44.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.304 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.15 9.03 59.41 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.216 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.8 p -116.34 -25.73 7.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.281 0.562 . . . . 0.0 109.932 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -79.6 170.4 16.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.208 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -148.29 131.61 16.55 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.666 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.4 -141.7 32.8 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.031 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 85.2 t -81.43 145.52 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 t -108.12 144.81 35.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.37 -21.11 3.44 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.073 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.409 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 32.9 m-80 -123.79 125.0 43.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.426 0.155 . . . . 0.0 111.213 -171.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.9 p-10 -77.71 -37.9 48.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 0.0 111.17 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.48 -38.32 21.44 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.57 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -63.78 -34.78 78.66 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 20.7 t -66.14 -47.9 72.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.926 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.645 ' O ' HG12 ' B' ' 26' ' ' ILE . 62.1 ttp180 -54.75 -52.59 62.07 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -55.29 -47.57 75.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.054 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -62.46 -47.15 85.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.224 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 96.5 m -54.9 -39.72 69.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.952 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.645 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.7 mm -58.34 -65.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.514 0.674 . . . . 0.0 110.989 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.446 ' HG3' ' HG ' ' B' ' 28' ' ' LEU . 17.3 ptp180 -71.94 -43.26 65.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.083 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' B' ' 27' ' ' ARG . 69.1 mt -88.16 -42.68 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -172.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.21 -0.1 28.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' B' ' 30' ' ' LYS . 7.1 mtmp? 66.29 25.46 10.48 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.322 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -77.32 152.09 34.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.928 0.394 . . . . 0.0 110.85 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 32.6 mmm180 -82.45 -33.42 28.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.494 0.664 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -147.68 160.47 42.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -152.44 151.33 23.19 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 15.3 t -150.31 152.57 34.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.037 0.419 . . . . 0.0 110.087 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 18' ' ' ASN . 15.6 t -91.45 66.19 5.4 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.754 0.788 . . . . 0.0 109.09 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.448 HD22 HG13 ' B' ' 46' ' ' ILE . 0.1 OUTLIER -74.92 157.02 35.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.464 -172.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -88.23 89.07 7.84 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.467 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.67 96.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 168.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -40.12 135.61 1.37 Allowed Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 123.823 0.702 . . . . 0.0 111.361 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -100.15 28.47 14.05 Favored 'Cis proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.956 -1.268 . . . . 0.0 114.065 3.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.42 33.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.118 0.485 . . . . 0.0 111.956 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -77.27 127.2 32.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.908 173.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -123.08 145.84 48.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 42.6 t -73.75 106.51 5.52 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 108.913 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.717 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 31.1 mm -110.39 110.16 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.155 0.502 . . . . 0.0 110.653 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 46.0 m -79.06 148.51 32.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.407 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' B' ' 3' ' ' LEU . 74.4 m-85 -112.7 123.85 51.24 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.088 0.47 . . . . 0.0 111.437 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.452 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 95.6 m-85 -121.41 134.83 24.62 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.123 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 51.4 Cg_exo -51.5 125.16 15.94 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.85 2.367 . . . . 0.0 112.58 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.77 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -76.52 96.11 4.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.958 0.885 . . . . 0.0 110.097 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.48 154.21 50.13 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.44 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 88.0 m -123.6 114.15 19.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.156 0.503 . . . . 0.0 109.753 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.649 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -68.38 153.07 44.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.262 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -142.47 125.94 9.51 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.163 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.496 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.5 Cg_endo -59.53 122.11 10.97 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.347 2.032 . . . . 0.0 111.742 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.4 p -49.49 128.97 18.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.483 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.92 5.67 42.93 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -114.39 -11.63 12.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.57 0.7 . . . . 0.0 110.257 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -92.41 171.1 9.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.876 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.8 m -154.49 139.25 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.602 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.51 -155.33 48.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.381 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.99 156.22 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 120.94 0.4 . . . . 0.0 110.075 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.22 147.35 40.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.446 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -142.71 22.76 2.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.821 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.2 p30 -158.17 137.19 11.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -173.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -88.6 -29.61 19.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.048 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.42 -56.68 2.77 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.683 -173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -58.55 -36.49 73.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.001 0.429 . . . . 0.0 109.928 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -61.44 -49.05 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.621 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.592 ' O ' HG12 ' B' ' 26' ' ' ILE . 35.9 ttm180 -63.44 -50.4 69.92 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 109.742 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -56.89 -43.18 81.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -58.7 -51.22 70.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.375 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 99.4 m -53.73 -40.58 66.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.186 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' B' ' 31' ' ' ALA . 19.0 mm -56.68 -58.33 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 121.375 0.607 . . . . 0.0 111.196 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' B' ' 27' ' ' ARG . 13.4 ptp180 -79.06 -45.84 19.31 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.925 -171.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -78.88 -60.26 2.45 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.602 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.91 3.55 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.431 . . . . 0.0 111.969 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 60.28 31.16 20.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.744 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -81.93 148.71 28.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.498 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -85.6 -25.61 26.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 0.0 111.489 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . 0.563 ' CE1' ' HD3' ' B' ' 22' ' ' ARG . 36.2 t60 -152.44 177.29 10.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.41 175.8 47.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.585 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 4.8 t -173.6 156.7 3.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 17.2 t -89.77 73.18 7.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.465 0.65 . . . . 0.0 109.258 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.602 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -65.44 151.79 45.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.186 -172.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -92.08 81.47 5.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.353 0.597 . . . . 0.0 110.406 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.55 99.23 5.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 34.9 t80 -44.0 132.86 4.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.452 -171.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 52.9 Cg_endo -101.21 23.36 17.43 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.13 -1.196 . . . . 0.0 114.205 2.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.5 158.12 41.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -90.58 125.33 35.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.865 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.52 151.74 50.67 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.094 0.473 . . . . 0.0 110.623 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.8 t -76.43 120.49 21.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.123 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.649 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 44.5 mm -123.24 116.67 49.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 35.9 m -86.02 136.86 33.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.879 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -101.12 123.33 45.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.863 0.363 . . . . 0.0 110.477 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 94.4 m-85 -116.27 138.46 24.29 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.686 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 13.4 Cg_exo -68.0 116.12 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.463 2.109 . . . . 0.0 111.781 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.31 -1.131 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.364 177.312 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.42 ' H ' ' HG3' ' B' ' 2' ' ' ARG . 0.0 OUTLIER -85.15 41.18 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 111.24 -177.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 50' ' ' PRO . 64.8 mt -127.09 136.16 51.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.553 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -112.98 118.06 33.77 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.617 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.3 mp0 -67.7 152.36 45.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.848 -173.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -142.55 131.73 11.93 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.13 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.55 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.0 Cg_endo -58.16 129.58 33.69 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.245 1.964 . . . . 0.0 111.697 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 39.7 t -58.09 132.53 53.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.09 0.471 . . . . 0.0 110.974 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.3 11.89 47.8 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -117.64 -20.66 8.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.573 0.702 . . . . 0.0 109.727 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -87.73 170.52 11.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.351 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 40.3 m -140.97 121.1 13.76 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.68 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.33 -152.03 51.54 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.746 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.72 148.4 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 8.0 p -110.62 146.88 35.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.762 0.315 . . . . 0.0 111.176 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.37 -7.36 34.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.332 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' B' ' 20' ' ' ALA . 42.8 m-80 -139.14 108.66 6.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.449 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -73.53 -31.47 63.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.744 0.307 . . . . 0.0 110.979 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.7 -38.87 22.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.337 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CB ' ' B' ' 17' ' ' ASN . . . -62.09 -38.74 90.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.97 -49.29 78.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.652 ' O ' HG12 ' B' ' 26' ' ' ILE . 43.5 ttp180 -54.31 -55.95 23.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' B' ' 27' ' ' ARG . 40.8 t30 -53.62 -46.99 70.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.551 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -60.65 -48.21 82.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.398 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 92.1 m -54.69 -40.7 69.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.032 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.652 HG12 ' O ' ' B' ' 22' ' ' ARG . 14.7 mm -58.92 -58.76 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 121.762 0.791 . . . . 0.0 110.303 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 23' ' ' ASN . 70.7 mtp180 -71.29 -51.81 22.35 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.281 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.01 -26.88 18.15 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -115.36 4.95 14.49 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.972 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 59.7 mttp 59.13 29.19 18.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.594 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -83.82 157.57 21.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.992 0.425 . . . . 0.0 110.475 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -90.0 -26.65 20.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.827 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -153.49 168.56 25.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.106 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.11 160.94 34.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -176.1 160.14 2.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 43' ' ' HIS . 69.8 m -85.29 91.35 8.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.412 ' ND2' ' CG1' ' B' ' 46' ' ' ILE . 0.0 OUTLIER -69.25 165.12 21.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -96.32 93.05 6.64 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.332 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -95.87 107.03 19.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.1 t80 -45.02 135.49 4.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.864 0.728 . . . . 0.0 111.572 -173.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.4 Cg_endo -100.07 21.61 21.01 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.807 -1.33 . . . . 0.0 113.508 1.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.9 178.81 6.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.353 0.596 . . . . 0.0 112.148 -172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' B' ' 36' ' ' CYS . 55.0 m-70 -100.27 119.03 37.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.087 175.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -107.81 145.13 34.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.616 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -72.53 115.2 11.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.52 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.617 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 37.8 mm -124.89 128.17 73.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 -174.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.7 m -96.86 151.75 19.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.702 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -111.48 125.44 53.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.4 142.14 31.99 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.201 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' B' ' 3' ' ' LEU . 76.3 Cg_exo -53.15 118.2 4.57 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.04 2.493 . . . . 0.0 112.392 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.691 -178.347 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.94 0.4 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -90.53 -166.56 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.16 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 50' ' ' PRO . 48.6 mt -44.42 132.47 6.02 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.758 0.662 . . . . 0.0 111.606 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 m -98.17 123.93 42.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.638 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -74.71 150.25 39.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.769 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.443 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 49.6 tttm -133.93 134.28 23.02 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.431 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.455 ' HA ' HD13 ' B' ' 46' ' ' ILE . 19.8 Cg_endo -62.03 130.66 31.63 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.672 1.581 . . . . 0.0 110.619 173.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -58.72 134.06 56.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.05 16.34 42.78 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -125.98 -26.57 3.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.056 0.455 . . . . 0.0 110.784 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -87.33 170.89 11.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.585 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.5 t -148.28 124.03 10.54 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.31 -162.81 54.31 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.78 144.12 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -92.53 167.54 11.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.801 0.334 . . . . 0.0 110.225 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.35 -11.25 10.81 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.891 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 43.5 m-80 -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.46 -41.43 76.22 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.564 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.39 -37.26 58.91 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.594 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.41 -38.73 92.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.74 -46.85 80.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.111 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.631 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.0 ttp180 -60.94 -52.41 65.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.839 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' B' ' 27' ' ' ARG . 40.0 t30 -53.48 -46.18 69.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.519 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -59.16 -48.45 81.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 82.3 m -54.64 -43.24 72.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.643 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.631 HG12 ' O ' ' B' ' 22' ' ' ARG . 20.5 mm -55.93 -55.54 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.399 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' B' ' 23' ' ' ASN . 23.2 mmt180 -74.74 -63.72 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.565 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.23 -48.79 26.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.836 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -92.68 -0.2 57.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.0 0.428 . . . . 0.0 111.709 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 59.69 38.59 21.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.06 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -88.69 150.82 22.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.399 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -83.54 -25.32 31.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -153.14 167.3 29.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.353 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.3 162.34 35.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 88.0 p -159.6 145.16 15.76 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.829 0.315 . . . . 0.0 110.155 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 6.8 t -82.33 76.18 9.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.464 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -67.43 152.46 45.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.298 -172.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -90.56 77.08 6.49 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.685 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.27 101.06 5.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 56.2 t80 -43.31 135.13 3.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.393 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 42.3 Cg_endo -101.22 25.94 15.45 Favored 'Cis proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.575 4.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 163.83 31.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . 0.452 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 42.8 m-70 -89.75 117.71 28.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.55 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -119.51 154.83 33.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.14 0.495 . . . . 0.0 110.53 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 12.2 t -76.36 110.48 10.92 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.249 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 43.2 mm -118.84 116.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 m -86.89 153.37 21.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.12 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -115.37 130.52 56.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.956 0.408 . . . . 0.0 111.066 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.1 m-85 -126.42 142.19 42.23 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.167 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.437 ' HA ' HD23 ' B' ' 3' ' ' LEU . 77.3 Cg_exo -52.16 118.97 5.08 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.803 2.335 . . . . 0.0 111.827 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.44 -177.253 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.478 0.18 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 3' ' ' LEU . 30.1 ptt180 -82.67 -170.03 2.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' B' ' 2' ' ' ARG . 33.4 mt -54.7 160.64 1.78 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.446 . . . . 0.0 110.803 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' B' ' 51' ' ' CYS . 72.1 m -117.05 116.85 28.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.461 0.648 . . . . 0.0 110.583 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.658 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.5 mp0 -74.72 149.51 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.902 -171.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -139.69 125.55 11.94 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.538 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.459 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.8 Cg_endo -53.71 125.45 18.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.626 2.218 . . . . 0.0 112.477 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -59.15 139.48 56.87 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.86 13.56 26.93 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -119.93 8.59 11.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.578 0.704 . . . . 0.0 109.898 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -124.45 172.25 9.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.538 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -167.56 158.03 11.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.3 -164.31 54.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.321 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -83.85 128.74 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 t -81.3 133.28 35.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -29.25 4.12 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.914 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -126.84 114.94 18.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 111.26 -168.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' B' ' 36' ' ' CYS . 27.3 p-10 -72.94 -32.8 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.95 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.52 -52.05 23.12 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.579 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.32 -37.67 72.85 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.9 t -61.5 -47.5 85.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.51 174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.66 ' O ' HG12 ' B' ' 26' ' ' ILE . 47.9 ttp85 -62.04 -49.51 75.7 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -59.33 -43.77 92.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.549 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' B' ' 24' ' ' GLN . 1.7 mt-30 -58.19 -45.75 86.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.771 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 87.2 m -60.23 -41.13 92.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.824 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.66 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.9 mm -58.33 -58.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.464 0.65 . . . . 0.0 110.642 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -73.79 -61.37 1.87 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.666 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 mt -74.46 -40.43 61.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.988 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -107.87 5.27 26.27 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.989 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt 56.75 32.86 21.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.965 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -80.99 149.56 29.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.627 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -77.85 -30.94 51.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.071 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -151.8 167.6 27.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.952 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.408 ' N ' ' HG3' ' B' ' 22' ' ' ARG . . . -161.33 165.05 35.3 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -160.58 155.44 24.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.974 0.387 . . . . 0.0 110.121 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' B' ' 43' ' ' HIS . 26.2 t -91.44 72.23 6.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -62.58 153.6 31.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.598 -172.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -96.54 79.55 3.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.857 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.2 101.25 4.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -46.35 134.73 7.42 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.703 -171.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -102.08 28.04 12.24 Favored 'Cis proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.049 -1.23 . . . . 0.0 113.849 2.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.0 170.81 15.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 112.13 -173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . 0.636 ' HB3' ' SG ' ' B' ' 36' ' ' CYS . 51.4 m-70 -100.01 130.16 46.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -127.65 148.47 50.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.267 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 35.4 t -74.21 117.33 15.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.658 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 36.1 mm -126.63 119.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.455 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 37.5 m -84.21 151.23 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.112 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.33 121.78 45.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.086 0.469 . . . . 0.0 111.09 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -121.37 135.32 24.92 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.236 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.88 117.85 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.283 1.989 . . . . 0.0 112.178 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' B' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.318 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.113 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.937 0.399 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -99.8 -163.1 1.0 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.394 . . . . 0.0 110.374 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.0 164.63 25.77 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.897 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 36.4 m -120.38 125.74 48.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.02 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.67 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.9 mp0 -76.89 139.09 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.401 0.62 . . . . 0.0 111.483 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' HD2' ' B' ' 49' ' ' PHE . 2.1 mptm? -132.46 141.46 41.33 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.211 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.33 138.46 60.78 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.06 1.84 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.9 p -59.76 131.79 51.99 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.371 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.08 14.61 33.79 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.488 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.8 p -131.85 -9.42 3.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.956 0.408 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . 0.517 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 19.4 t-105 -104.86 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.321 0.582 . . . . 0.0 110.376 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' B' ' 11' ' ' TRP . 26.9 m -89.7 -155.97 0.39 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.768 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.61 -116.14 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 113.242 175.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -58.57 147.74 6.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.487 . . . . 0.0 111.347 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 6.5 p -130.64 147.93 52.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.227 0.537 . . . . 0.0 110.929 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.64 -45.48 6.41 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.246 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 40.9 m-80 -116.51 126.98 54.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.765 0.317 . . . . 0.0 110.792 -173.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -70.38 -28.08 64.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.417 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.65 -34.42 25.15 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.751 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -64.98 -38.58 91.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -61.5 -49.24 77.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.792 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.634 ' O ' HG12 ' B' ' 26' ' ' ILE . 50.1 ttp180 -52.5 -55.3 22.96 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.155 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -51.96 -48.58 64.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.903 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -64.0 -44.71 91.84 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.143 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 74.6 m -55.56 -41.12 72.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.453 174.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.634 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.1 mm -56.97 -59.14 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.47 0.653 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -80.69 -51.02 9.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.345 -169.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 82.2 mt -79.36 -42.92 24.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.75 1.46 37.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' B' ' 26' ' ' ILE . 34.7 mmtp 57.81 29.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.885 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -78.26 151.35 33.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.985 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' B' ' 32' ' ' ARG . 4.3 mmp_? -83.11 -24.93 32.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -153.56 167.01 30.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.482 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.34 158.64 31.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 69.3 m -162.18 151.99 16.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.074 0.437 . . . . 0.0 110.539 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -76.38 81.83 3.12 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.203 0.525 . . . . 0.0 109.986 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.42 HD22 HG13 ' B' ' 46' ' ' ILE . 0.0 OUTLIER -78.17 156.98 29.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -175.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.98 83.2 7.85 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.835 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 95.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 167.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 82.7 t80 -44.26 135.04 4.26 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.628 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 31.8 Cg_endo -100.03 29.92 12.44 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.874 -1.302 . . . . 0.0 113.807 1.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.33 167.49 21.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.324 0.583 . . . . 0.0 112.052 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -91.37 111.07 22.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.827 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -105.75 147.39 28.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.722 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.5 t -73.6 114.98 12.47 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 30.1 mm -121.13 118.52 56.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.112 0.482 . . . . 0.0 110.887 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 55.6 m -84.78 148.3 26.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.817 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.01 121.5 45.53 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.922 0.391 . . . . 0.0 110.916 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' B' ' 6' ' ' LYS . 98.0 m-85 -117.87 138.56 25.47 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.341 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.85 123.15 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.645 2.23 . . . . 0.0 111.982 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.859 178.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -80.69 46.69 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.53 0.681 . . . . 0.0 110.5 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 50' ' ' PRO . 67.0 mt -125.84 136.3 52.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.028 -171.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 22.8 m -110.75 122.72 48.52 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.678 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 2.0 mp0 -75.55 152.39 37.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.429 0.633 . . . . 0.0 112.035 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.441 ' HD3' ' CE2' ' B' ' 49' ' ' PHE . 64.2 tttp -137.79 131.32 16.95 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.436 ' HA ' HD13 ' B' ' 46' ' ' ILE . 17.9 Cg_endo -60.53 124.91 16.04 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.117 1.878 . . . . 0.0 111.203 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -51.91 133.45 32.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' B' ' 29' ' ' GLU . . . -102.17 3.78 51.61 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.7 p -115.13 -20.45 10.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.53 0.681 . . . . 0.0 110.076 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -90.63 167.06 12.82 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.012 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -158.25 151.02 22.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.737 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.83 -149.64 45.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.939 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.18 139.65 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-O 120.815 0.341 . . . . 0.0 110.603 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 13.0 t -104.28 148.32 26.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.144 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.62 32.25 1.22 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.86 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.576 ' OD1' ' HB3' ' B' ' 20' ' ' ALA . 4.8 p30 -165.06 129.79 2.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -89.25 -30.8 18.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.706 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.84 -49.8 5.51 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.219 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' B' ' 17' ' ' ASN . . . -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -61.27 -47.93 83.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.269 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.588 ' O ' HG12 ' B' ' 26' ' ' ILE . 55.5 ttp180 -60.75 -51.32 69.85 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.121 0.486 . . . . 0.0 109.746 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -55.08 -48.69 73.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.176 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.408 ' CG ' HD12 ' B' ' 28' ' ' LEU . 17.0 tt0 -60.51 -45.04 95.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.386 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 98.8 m -56.17 -42.76 77.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.588 HG12 ' O ' ' B' ' 22' ' ' ARG . 21.8 mm -54.88 -56.72 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.746 0.784 . . . . 0.0 111.004 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -79.88 -63.6 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.828 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CG ' ' B' ' 24' ' ' GLN . 83.0 mt -72.18 -35.75 69.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.684 -170.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' B' ' 9' ' ' GLY . 35.2 mt-10 -108.46 3.4 23.15 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.929 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp 58.67 34.32 23.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.041 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -86.77 154.61 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.333 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -90.1 -22.38 21.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.24 166.27 33.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.02 161.73 31.72 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -152.62 144.77 23.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.807 0.304 . . . . 0.0 110.666 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 35.8 t -90.43 79.94 6.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' ND2' HG13 ' B' ' 46' ' ' ILE . 23.1 p-10 -71.07 167.78 18.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.316 -171.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -110.62 77.37 1.04 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.075 0.464 . . . . 0.0 110.273 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -80.52 102.1 6.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 55.9 t80 -43.22 137.2 2.85 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.173 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 44.1 Cg_endo -99.86 24.54 18.7 Favored 'Cis proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.155 -1.185 . . . . 0.0 114.694 3.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.92 163.4 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 112.241 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 54.9 m-70 -86.24 128.12 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.303 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -118.01 168.88 10.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.166 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.02 116.08 28.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.678 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 45.8 mm -115.98 117.15 54.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.534 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 56.2 m -85.01 145.48 27.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' B' ' 3' ' ' LEU . 3.5 m-85 -110.02 122.53 47.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.923 0.392 . . . . 0.0 110.766 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HD3' ' B' ' 6' ' ' LYS . 98.0 m-85 -116.5 139.19 25.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.874 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HA ' HD23 ' B' ' 3' ' ' LEU . 53.4 Cg_exo -53.14 115.68 2.44 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.811 2.341 . . . . 0.0 111.656 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.263 -174.308 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.094 0.474 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -90.2 -178.1 5.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 0.0 111.76 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 50' ' ' PRO . 52.0 mt -108.75 145.67 34.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.915 -175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 99.0 m -109.17 129.0 55.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.597 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 1.0 OUTLIER -84.19 147.91 27.03 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.491 0.662 . . . . 0.0 112.019 -170.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -136.29 126.4 16.25 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.679 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.565 ' HA ' HD13 ' B' ' 46' ' ' ILE . 26.9 Cg_exo -60.45 133.68 50.44 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.069 1.846 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 79.2 p -53.08 127.77 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.565 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.89 4.07 56.01 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 29.4 p -120.17 -0.88 10.4 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.48 0.657 . . . . 0.0 110.334 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . 0.46 ' NE1' ' HB3' ' B' ' 15' ' ' CYS . 6.3 t-105 -126.21 169.83 12.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -160.66 133.31 6.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.24 -165.67 34.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.942 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.99 120.32 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.057 0.456 . . . . 0.0 110.003 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' B' ' 11' ' ' TRP . 3.3 p -88.85 135.65 33.42 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.95 38.57 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.815 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . 41.6 m-80 -122.01 120.89 35.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.805 0.336 . . . . 0.0 110.553 -173.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -66.67 -31.18 71.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.693 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.74 -36.45 37.18 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.49 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' B' ' 17' ' ' ASN . . . -63.79 -38.51 91.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 25.5 t -59.93 -47.25 86.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.72 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.671 ' O ' HG12 ' B' ' 26' ' ' ILE . 38.9 ttt180 -58.95 -52.13 67.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -58.42 -36.51 73.73 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.321 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.411 ' NE2' ' HE3' ' B' ' 11' ' ' TRP . 0.0 OUTLIER -69.29 -43.8 73.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' B' ' 31' ' ' ALA . 72.7 m -58.73 -40.19 83.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.596 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.671 HG12 ' O ' ' B' ' 22' ' ' ARG . 26.8 mm -54.61 -60.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.71 0.767 . . . . 0.0 110.756 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -69.02 -61.9 1.6 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.757 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -79.95 -43.24 22.45 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.223 -168.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.57 1.2 40.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.939 -172.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 58.9 36.0 24.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.968 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' B' ' 25' ' ' CYS . . . -88.35 151.12 22.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.338 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -83.73 -33.43 25.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . 0.534 ' CE1' ' HD2' ' B' ' 22' ' ' ARG . 73.5 t60 -139.66 166.48 24.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 22' ' ' ARG . . . -161.95 156.4 27.94 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -170.14 154.03 4.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.199 0.499 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' B' ' 44' ' ' LYS . 84.1 m -84.89 81.44 8.89 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.521 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 160.64 11.99 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.675 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -98.56 85.24 3.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 111.497 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.78 104.61 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 71.7 t80 -46.65 135.55 7.78 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.365 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 40' ' ' PHE . 68.9 Cg_endo -99.59 21.37 22.27 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.962 -1.266 . . . . 0.0 113.417 0.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.5 -175.51 3.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.275 0.559 . . . . 0.0 111.834 -172.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -114.98 133.41 56.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.092 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' B' ' 36' ' ' CYS . 40.0 mmtm -123.53 148.98 45.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.287 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 52.3 t -74.62 120.54 20.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.209 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.597 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 32.6 mm -127.11 119.72 53.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 25.4 m -86.68 142.57 28.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.487 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.478 ' HB2' ' HB3' ' B' ' 33' ' ' HIS . 85.0 m-85 -110.58 122.57 48.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.042 0.448 . . . . 0.0 111.048 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' B' ' 50' ' ' PRO . 90.7 m-85 -113.91 135.31 22.04 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.484 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 49' ' ' PHE . 38.4 Cg_exo -59.4 125.04 16.84 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.042 2.495 . . . . 0.0 113.072 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.298 -0.858 . . . . 0.0 109.953 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.838 0.351 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -121.46 -168.46 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.183 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt -54.05 152.18 6.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.8 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -93.03 120.35 33.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.954 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' B' ' 46' ' ' ILE . 7.9 mp0 -81.98 136.48 35.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.946 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -131.01 123.85 20.19 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.408 ' HA ' HD13 ' B' ' 46' ' ' ILE . 9.6 Cg_endo -53.55 125.99 20.33 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.544 2.163 . . . . 0.0 111.909 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.2 t -55.82 143.66 30.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.285 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.91 10.87 20.79 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.189 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.1 p -118.44 -19.24 8.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' B' ' 15' ' ' CYS . 7.3 t-105 -98.66 171.77 7.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.987 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.0 p -157.17 129.02 7.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.91 -148.27 39.49 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.674 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 142.31 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 120.919 0.39 . . . . 0.0 110.347 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.484 ' HA ' ' NE1' ' B' ' 11' ' ' TRP . 15.6 p -96.03 170.68 9.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.03 -62.79 2.28 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.592 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -154.22 167.19 30.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -54.37 -50.47 67.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.41 0.444 . . . . 0.0 111.852 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.32 -36.22 78.09 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.243 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.26 78.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.155 0.503 . . . . 0.0 109.795 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' B' ' 36' ' ' CYS . 25.3 t -69.18 -46.65 66.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.825 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.64 ' O ' HG12 ' B' ' 26' ' ' ILE . 42.9 ttp180 -56.64 -54.4 46.47 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.953 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -61.98 -48.71 79.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.159 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -54.9 -41.09 70.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.027 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.64 HG12 ' O ' ' B' ' 22' ' ' ARG . 18.5 mm -56.09 -60.15 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.772 0.796 . . . . 0.0 110.475 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 27' ' ' ARG . 42.0 mtm180 -72.95 -56.17 5.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.88 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 75.6 mt -81.64 -32.56 31.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.795 -169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -112.47 6.48 18.59 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.609 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 55.35 35.23 24.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.431 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' B' ' 26' ' ' ILE . . . -84.21 153.47 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.852 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -88.03 -28.2 21.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 0.0 110.778 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -148.81 171.12 16.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.49 156.75 26.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 62.6 m -161.56 134.85 6.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' B' ' 21' ' ' CYS . 97.4 m -67.04 139.0 57.61 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.958 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' B' ' 43' ' ' HIS . 36.0 p-10 -117.6 169.86 9.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.202 -175.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -109.79 64.32 0.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.244 0.545 . . . . 0.0 110.248 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -75.76 92.8 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 167.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 41' ' ' PRO . 81.5 t80 -46.47 138.15 6.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.851 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' B' ' 40' ' ' PHE . 31.3 Cg_endo -100.26 29.62 12.59 Favored 'Cis proline' 0 N--CA 1.46 -0.485 0 C-N-CA 124.143 -1.191 . . . . 0.0 114.758 4.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.73 151.02 46.77 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.418 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' B' ' 37' ' ' ASN . 9.2 m-70 -89.96 91.99 8.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.875 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.33 174.02 11.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.005 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 45.4 t -100.1 116.47 32.2 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.079 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.662 ' CG2' ' HB3' ' B' ' 5' ' ' GLU . 35.4 mm -116.08 116.51 52.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.056 0.455 . . . . 0.0 110.427 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 m -83.38 149.83 26.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.054 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.29 125.07 53.89 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.058 0.456 . . . . 0.0 111.032 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -119.56 139.69 28.24 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.545 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.19 124.82 17.19 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.807 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 43.4 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.127 178.126 . . . . . . . . 0 0 . 1 stop_ save_